{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:52:45Z","timestamp":1793137965846,"version":"4.5.0"},"reference-count":185,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s10555-022-10069-9","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T15:14:09Z","timestamp":1673277249000},"page":"277-296","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Mesenchymal stromal cell senescence in haematological malignancies"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6365-9713","authenticated-orcid":false,"given":"Natalya","family":"Plakhova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6879-1262","authenticated-orcid":false,"given":"Vasilios","family":"Panagopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1033-849X","authenticated-orcid":false,"given":"Kate","family":"Vandyke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6646-6167","authenticated-orcid":false,"given":"Andrew C. W.","family":"Zannettino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4890-8208","authenticated-orcid":false,"given":"Krzysztof M.","family":"Mrozik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,9]]},"reference":[{"issue":"2","key":"10069_CR1","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.cell.2012.06.023","volume":"150","author":"JS Welch","year":"2012","unstructured":"Welch, J. S., Ley, T. J., Link, D. C., Miller, C. A., Larson, D. E., Koboldt, D. C., Wartman, L. D., Lamprecht, T. L., Liu, F., Xia, J., Kandoth, C., Fulton, R. S., McLellan, M. D., Dooling, D. J., Wallis, J. W., Chen, K., Harris, C. C., Schmidt, H. K., Kalicki-Veizer, J. M., Lu, C., et al. (2012). The origin and evolution of mutations in acute myeloid leukemia. Cell, 150(2), 264\u2013278. https:\/\/doi.org\/10.1016\/j.cell.2012.06.023","journal-title":"Cell"},{"issue":"1","key":"10069_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","volume":"126","author":"DP Steensma","year":"2015","unstructured":"Steensma, D. P., Bejar, R., Jaiswal, S., Lindsley, R. C., Sekeres, M. A., Hasserjian, R. P., & Ebert, B. L. (2015). Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood, 126(1), 9\u201316. https:\/\/doi.org\/10.1182\/blood-2015-03-631747","journal-title":"Blood"},{"issue":"21","key":"10069_CR3","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1182\/blood.V124.21.840.840","volume":"124","author":"S Jaiswal","year":"2014","unstructured":"Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P., Mar, B. G., Lindsley, R. C., Mermel, C., Burtt, N., Chavez, A., Higgins, J. M., Moltchanov, V., Kinnunen, L., Koistinen, H., Ladenvall, C., Getz, G., Correa, A., Gabriel, S., Kathiresan, S., Stringham, H., et al. (2014). Clonal hematopoiesis with somatic mutations is a common, age-related condition associated with adverse outcomes. Blood, 124(21), 840. https:\/\/doi.org\/10.1056\/NEJMoa1408617","journal-title":"Blood"},{"key":"10069_CR4","doi-asserted-by":"publisher","first-page":"12484","DOI":"10.1038\/ncomms12484","volume":"7","author":"AL Young","year":"2016","unstructured":"Young, A. L., Challen, G. A., Birmann, B. M., & Druley, T. E. (2016). Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults. Nature Communucations, 7, 12484. https:\/\/doi.org\/10.1038\/ncomms12484","journal-title":"Nature Communucations"},{"key":"10069_CR5","doi-asserted-by":"publisher","unstructured":"Veiga, C. B., Lawrence, E. M., Murphy, A. J., Herold, M. J., & Dragoljevic, D. (2021). Myelodysplasia syndrome, clonal hematopoiesis and cardiovascular disease. Cancers, 13(8), 1968. https:\/\/doi.org\/10.3390\/cancers13081968","DOI":"10.3390\/cancers13081968"},{"issue":"4","key":"10069_CR6","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1182\/blood-2015-02-585059","volume":"126","author":"P Strati","year":"2015","unstructured":"Strati, P., & Shanafelt, T. D. (2015). Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: Diagnosis, natural history, and risk stratification. Blood, 126(4), 454\u2013462. https:\/\/doi.org\/10.1182\/blood-2015-02-585059","journal-title":"Blood"},{"issue":"3","key":"10069_CR7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMoa1709974","volume":"378","author":"RA Kyle","year":"2018","unstructured":"Kyle, R. A., Larson, D. R., Therneau, T. M., Dispenzieri, A., Kumar, S., Cerhan, J. R., & Rajkumar, S. V. (2018). Long-term follow-up of monoclonal gammopathy of undetermined significance. New England Journal of Medicine, 378(3), 241\u2013249. https:\/\/doi.org\/10.1056\/NEJMoa1709974","journal-title":"New England Journal of Medicine"},{"issue":"26","key":"10069_CR8","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","volume":"371","author":"G Genovese","year":"2014","unstructured":"Genovese, G., Kahler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., Purcell, S. M., Svantesson, O., Landen, M., Hoglund, M., Lehmann, S., Gabriel, S. B., Moran, J. L., Lander, E. S., Sullivan, P. F., Sklar, P., et al. (2014). Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. New England Journal of Medicine, 371(26), 2477\u20132487. https:\/\/doi.org\/10.1056\/NEJMoa1409405","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10069_CR9","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1002\/cncr.22570","volume":"109","author":"X Ma","year":"2007","unstructured":"Ma, X., Does, M., Raza, A., & Mayne, S. T. (2007). Myelodysplastic syndromes: Incidence and survival in the United States. Cancer, 109(8), 1536\u20131542. https:\/\/doi.org\/10.1002\/cncr.22570","journal-title":"Cancer"},{"key":"10069_CR10","doi-asserted-by":"publisher","unstructured":"Shim, Y. K., Middleton, D. C., Caporaso, N. E., Rachel, J. M., Landgren, O., Abbasi, F., Raveche, E. S., Rawstron, A. C., Orfao, A., Marti, G. E., & Vogt, R. F. (2010). Prevalence of monoclonal B-cell lymphocytosis: a systematic review. Cytometry. Part B: Clinical Cytometry, 78. https:\/\/doi.org\/10.1002\/cyto.b.20538","DOI":"10.1002\/cyto.b.20538"},{"issue":"13","key":"10069_CR11","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJMoa054494","volume":"354","author":"RA Kyle","year":"2006","unstructured":"Kyle, R. A., Therneau, T. M., Rajkumar, S. V., Larson, D. R., Plevak, M. F., Offord, J. R., Dispenzieri, A., Katzmann, J. A., & Melton, L. J., 3rd. (2006). Prevalence of monoclonal gammopathy of undetermined significance. New England Journal of Medicine, 354(13), 1362\u20131369. https:\/\/doi.org\/10.1056\/NEJMoa054494","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10069_CR12","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1182\/bloodadvances.2016002493","volume":"1","author":"LJ Costa","year":"2017","unstructured":"Costa, L. J., Brill, I. K., Omel, J., Godby, K., Kumar, S. K., & Brown, E. E. (2017). Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States. Blood Advances, 1(4), 282\u2013287. https:\/\/doi.org\/10.1182\/bloodadvances.2016002493","journal-title":"Blood Advances"},{"issue":"10129","key":"10069_CR13","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/S0140-6736(18)30422-7","volume":"391","author":"M Hallek","year":"2018","unstructured":"Hallek, M., Shanafelt, T. D., & Eichhorst, B. (2018). Chronic lymphocytic leukaemia. Lancet, 391(10129), 1524\u20131537. https:\/\/doi.org\/10.1016\/S0140-6736(18)30422-7","journal-title":"Lancet"},{"issue":"12","key":"10069_CR14","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.3324\/haematol.2012.066100","volume":"97","author":"B Oran","year":"2012","unstructured":"Oran, B., & Weisdorf, D. J. (2012). Survival for older patients with acute myeloid leukemia: A population-based study. Haematologica, 97(12), 1916\u20131924. https:\/\/doi.org\/10.3324\/haematol.2012.066100","journal-title":"Haematologica"},{"issue":"12","key":"10069_CR15","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.18632\/aging.100707","volume":"6","author":"AI Rozhok","year":"2014","unstructured":"Rozhok, A. I., Salstrom, J. L., & DeGregori, J. (2014). Stochastic modeling indicates that aging and somatic evolution in the hematopoetic system are driven by non-cell-autonomous processes. Aging, 6(12), 1033\u20131048. https:\/\/doi.org\/10.18632\/aging.100707","journal-title":"Aging"},{"issue":"2","key":"10069_CR16","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41375-018-0206-x","volume":"33","author":"AK Dutta","year":"2019","unstructured":"Dutta, A. K., Fink, J. L., Grady, J. P., Morgan, G. J., Mullighan, C. G., To, L. B., Hewett, D. R., & Zannettino, A. C. W. (2019). Subclonal evolution in disease progression from MGUS\/SMM to multiple myeloma is characterised by clonal stability. Leukemia, 33(2), 457\u2013468. https:\/\/doi.org\/10.1038\/s41375-018-0206-x","journal-title":"Leukemia"},{"issue":"11","key":"10069_CR17","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/nm.4202","volume":"22","author":"R Das","year":"2016","unstructured":"Das, R., Strowig, T., Verma, R., Koduru, S., Hafemann, A., Hopf, S., Kocoglu, M. H., Borsotti, C., Zhang, L., Branagan, A., Eynon, E., Manz, M. G., Flavell, R. A., & Dhodapkar, M. V. (2016). Microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice. Nature Medicine, 22(11), 1351\u20131357. https:\/\/doi.org\/10.1038\/nm.4202","journal-title":"Nature Medicine"},{"issue":"6","key":"10069_CR18","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.stem.2014.02.014","volume":"14","author":"H Medyouf","year":"2014","unstructured":"Medyouf, H., Mossner, M., Jann, J.-C., Nolte, F., Raffel, S., Herrmann, C., Lier, A., Eisen, C., Nowak, V., Zens, B., M\u00fcdder, K., Klein, C., Obl\u00e4nder, J., Fey, S., Vogler, J., Fabarius, A., Riedl, E., Roehl, H., Kohlmann, A., Staller, M., et al. (2014). Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit. Cell Stem Cell, 14(6), 824\u2013837. https:\/\/doi.org\/10.1016\/j.stem.2014.02.014","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10069_CR19","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1182\/blood-2015-06-653113","volume":"127","author":"SR Balderman","year":"2016","unstructured":"Balderman, S. R., Li, A. J., Hoffman, C. M., Frisch, B. J., Goodman, A. N., LaMere, M. W., Georger, M. A., Evans, A. G., Liesveld, J. L., Becker, M. W., & Calvi, L. M. (2016). Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndrome. Blood, 127(5), 616\u2013625. https:\/\/doi.org\/10.1182\/blood-2015-06-653113","journal-title":"Blood"},{"key":"10069_CR20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nature16932","volume":"530","author":"DJ Baker","year":"2016","unstructured":"Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., Saltness, A., & R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., Khazaie, K., Miller, J. D., & van Deursen, J. M. (2016). Naturally occurring p16Ink4a-positive cells shorten healthy lifespan. Nature, 530, 184. https:\/\/doi.org\/10.1038\/nature16932","journal-title":"Nature"},{"issue":"6","key":"10069_CR21","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/nm.4324","volume":"23","author":"OH Jeon","year":"2017","unstructured":"Jeon, O. H., Kim, C., Laberge, R. M., Demaria, M., Rathod, S., Vasserot, A. P., Chung, J. W., Kim, D. H., Poon, Y., David, N., Baker, D. J., van Deursen, J. M., Campisi, J., & Elisseeff, J. H. (2017). Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment. Nature Medicine, 23(6), 775\u2013781. https:\/\/doi.org\/10.1038\/nm.4324","journal-title":"Nature Medicine"},{"issue":"11","key":"10069_CR22","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1002\/jbmr.2892","volume":"31","author":"JN Farr","year":"2016","unstructured":"Farr, J. N., Fraser, D. G., Wang, H., Jaehn, K., Ogrodnik, M. B., Weivoda, M. M., Drake, M. T., Tchkonia, T., LeBrasseur, N. K., Kirkland, J. L., Bonewald, L. F., Pignolo, R. J., Monroe, D. G., & Khosla, S. (2016). Identification of Senescent Cells in the Bone Microenvironment. Journal of Bone and Mineral Research, 31(11), 1920\u20131929. https:\/\/doi.org\/10.1002\/jbmr.2892","journal-title":"Journal of Bone and Mineral Research"},{"issue":"4","key":"10069_CR23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1593\/neo.91948","volume":"12","author":"K Lawrenson","year":"2010","unstructured":"Lawrenson, K., Grun, B., Benjamin, E., Jacobs, I. J., Dafou, D., & Gayther, S. A. (2010). Senescent fibroblasts promote neoplastic transformation of partially transformed ovarian epithelial cells in a three-dimensional model of early stage ovarian cancer. Neoplasia, 12(4), 317\u2013325. https:\/\/doi.org\/10.1593\/neo.91948","journal-title":"Neoplasia"},{"issue":"21","key":"10069_CR24","doi-asserted-by":"publisher","first-page":"12072","DOI":"10.1073\/pnas.211053698","volume":"98","author":"A Krtolica","year":"2001","unstructured":"Krtolica, A., Parrinello, S., Lockett, S., Desprez, P. Y., & Campisi, J. (2001). Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging. Proceedings of the National Academy of Sciences of the United States of America, 98(21), 12072\u201312077. https:\/\/doi.org\/10.1073\/pnas.211053698","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10069_CR25","doi-asserted-by":"publisher","first-page":"e9188","DOI":"10.1371\/journal.pone.0009188","volume":"5","author":"JP Copp\u00e9","year":"2010","unstructured":"Copp\u00e9, J. P., Patil, C. K., Rodier, F., Krtolica, A., Beaus\u00e9jour, C. M., Parrinello, S., Hodgson, J. G., Chin, K., Desprez, P. Y., & Campisi, J. (2010). A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen. PLoS ONE, 5(2), e9188. https:\/\/doi.org\/10.1371\/journal.pone.0009188","journal-title":"PLoS ONE"},{"issue":"11","key":"10069_CR26","doi-asserted-by":"publisher","first-page":"e113572","DOI":"10.1371\/journal.pone.0113572","volume":"9","author":"GH Di","year":"2014","unstructured":"Di, G. H., Liu, Y., Lu, Y., Liu, J., Wu, C., & Duan, H. F. (2014). IL-6 secreted from senescent mesenchymal stem cells promotes proliferation and migration of breast cancer cells. PLoS ONE, 9(11), e113572. https:\/\/doi.org\/10.1371\/journal.pone.0113572","journal-title":"PLoS ONE"},{"issue":"8","key":"10069_CR27","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/ncb3195","volume":"17","author":"RM Laberge","year":"2015","unstructured":"Laberge, R. M., Sun, Y., Orjalo, A. V., Patil, C. K., Freund, A., Zhou, L., Curran, S. C., Davalos, A. R., Wilson-Edell, K. A., Liu, S., Limbad, C., Demaria, M., Li, P., Hubbard, G. B., Ikeno, Y., Javors, M., Desprez, P. Y., Benz, C. C., Kapahi, P., Nelson, P. S., et al. (2015). MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nature Cell Biology, 17(8), 1049\u20131061. https:\/\/doi.org\/10.1038\/ncb3195","journal-title":"Nature Cell Biology"},{"issue":"7","key":"10069_CR28","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1158\/0008-5472.Can-06-3452","volume":"67","author":"D Liu","year":"2007","unstructured":"Liu, D., & Hornsby, P. J. (2007). Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. Cancer Research, 67(7), 3117\u20133126. https:\/\/doi.org\/10.1158\/0008-5472.Can-06-3452","journal-title":"Cancer Research"},{"issue":"1","key":"10069_CR29","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.celrep.2015.12.016","volume":"14","author":"X Luo","year":"2016","unstructured":"Luo, X., Fu, Y., Loza, A. J., Murali, B., Leahy, K. M., Ruhland, M. K., Gang, M., Su, X., Zamani, A., Shi, Y., Lavine, K. J., Ornitz, D. M., Weilbaecher, K. N., Long, F., Novack, D. V., Faccio, R., Longmore, G. D., & Stewart, S. A. (2016). Stromal-initiated changes in the bone promote metastatic niche development. Cell Reports, 14(1), 82\u201392. https:\/\/doi.org\/10.1016\/j.celrep.2015.12.016","journal-title":"Cell Reports"},{"issue":"4","key":"10069_CR30","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Keating, A., Prockop, D., & Horwitz, E. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8(4), 315\u2013317. https:\/\/doi.org\/10.1080\/14653240600855905","journal-title":"Cytotherapy"},{"issue":"8","key":"10069_CR31","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s00018-017-2725-4","volume":"75","author":"M Goulard","year":"2018","unstructured":"Goulard, M., Dosquet, C., & Bonnet, D. (2018). Role of the microenvironment in myeloid malignancies. Cellular and Molecular Life Sciences, 75(8), 1377\u20131391. https:\/\/doi.org\/10.1007\/s00018-017-2725-4","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"8","key":"10069_CR32","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/nm.3647","volume":"20","author":"A Mendelson","year":"2014","unstructured":"Mendelson, A., & Frenette, P. S. (2014). Hematopoietic stem cell niche maintenance during homeostasis and regeneration. Nature Medicine, 20(8), 833\u2013846. https:\/\/doi.org\/10.1038\/nm.3647","journal-title":"Nature Medicine"},{"issue":"4","key":"10069_CR33","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.immuni.2018.03.024","volume":"48","author":"Q Wei","year":"2018","unstructured":"Wei, Q., & Frenette, P. S. (2018). Niches for Hematopoietic Stem Cells and Their Progeny. Immunity, 48(4), 632\u2013648. https:\/\/doi.org\/10.1016\/j.immuni.2018.03.024","journal-title":"Immunity"},{"key":"10069_CR34","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.3389\/fimmu.2020.01540","volume":"11","author":"I Mitroulis","year":"2020","unstructured":"Mitroulis, I., Kalafati, L., Bornhauser, M., Hajishengallis, G., & Chavakis, T. (2020). Regulation of the bone marrow niche by inflammation. Frontiers in Immunology, 11, 1540. https:\/\/doi.org\/10.3389\/fimmu.2020.01540","journal-title":"Frontiers in Immunology"},{"issue":"11","key":"10069_CR35","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1084\/jem.20050967","volume":"202","author":"E Passegue","year":"2005","unstructured":"Passegue, E., Wagers, A. J., Giuriato, S., Anderson, W. C., & Weissman, I. L. (2005). Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. Journal of Experimental Medicine, 202(11), 1599\u20131611. https:\/\/doi.org\/10.1084\/jem.20050967","journal-title":"Journal of Experimental Medicine"},{"issue":"7473","key":"10069_CR36","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nature12612","volume":"502","author":"Y Kunisaki","year":"2013","unstructured":"Kunisaki, Y., Bruns, I., Scheiermann, C., Ahmed, J., Pinho, S., Zhang, D., Mizoguchi, T., Wei, Q., Lucas, D., Ito, K., Mar, J. C., Bergman, A., & Frenette, P. S. (2013). Arteriolar niches maintain haematopoietic stem cell quiescence. Nature, 502(7473), 637\u2013643. https:\/\/doi.org\/10.1038\/nature12612","journal-title":"Nature"},{"issue":"7571","key":"10069_CR37","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nature15250","volume":"526","author":"M Acar","year":"2015","unstructured":"Acar, M., Kocherlakota, K. S., Murphy, M. M., Peyer, J. G., Oguro, H., Inra, C. N., Jaiyeola, C., Zhao, Z., Luby-Phelps, K., & Morrison, S. J. (2015). Deep imaging of bone marrow shows non-dividing stem cells are mainly perisinusoidal. Nature, 526(7571), 126\u2013130. https:\/\/doi.org\/10.1038\/nature15250","journal-title":"Nature"},{"issue":"6","key":"10069_CR38","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.immuni.2006.10.016","volume":"25","author":"T Sugiyama","year":"2006","unstructured":"Sugiyama, T., Kohara, H., Noda, M., & Nagasawa, T. (2006). Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity, 25(6), 977\u2013988. https:\/\/doi.org\/10.1016\/j.immuni.2006.10.016","journal-title":"Immunity"},{"issue":"3","key":"10069_CR39","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.immuni.2010.08.017","volume":"33","author":"Y Omatsu","year":"2010","unstructured":"Omatsu, Y., Sugiyama, T., Kohara, H., Kondoh, G., Fujii, N., Kohno, K., & Nagasawa, T. (2010). The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche. Immunity, 33(3), 387\u2013399. https:\/\/doi.org\/10.1016\/j.immuni.2010.08.017","journal-title":"Immunity"},{"issue":"7308","key":"10069_CR40","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nature09262","volume":"466","author":"S Mendez-Ferrer","year":"2010","unstructured":"Mendez-Ferrer, S., Michurina, T. V., Ferraro, F., Mazloom, A. R., Macarthur, B. D., Lira, S. A., Scadden, D. T., Ma\u2019ayan, A., Enikolopov, G. N., & Frenette, P. S. (2010). Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature, 466(7308), 829\u2013834. https:\/\/doi.org\/10.1038\/nature09262","journal-title":"Nature"},{"issue":"2","key":"10069_CR41","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.stem.2014.06.008","volume":"15","author":"BO Zhou","year":"2014","unstructured":"Zhou, B. O., Yue, R., Murphy, M. M., Peyer, J. G., & Morrison, S. J. (2014). Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. Cell Stem Cell, 15(2), 154\u2013168. https:\/\/doi.org\/10.1016\/j.stem.2014.06.008","journal-title":"Cell Stem Cell"},{"key":"10069_CR42","doi-asserted-by":"publisher","first-page":"8983","DOI":"10.1038\/ncomms9983","volume":"6","author":"MA Lawson","year":"2015","unstructured":"Lawson, M. A., McDonald, M. M., Kovacic, N., Hua Khoo, W., Terry, R. L., Down, J., Kaplan, W., Paton-Hough, J., Fellows, C., Pettitt, J. A., Neil Dear, T., Van Valckenborgh, E., Baldock, P. A., Rogers, M. J., Eaton, C. L., Vanderkerken, K., Pettit, A. R., Quinn, J. M., Zannettino, A. C., Phan, T. G., et al. (2015). Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche. Nature Communications, 6, 8983. https:\/\/doi.org\/10.1038\/ncomms9983","journal-title":"Nature Communications"},{"key":"10069_CR43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/bs.acr.2015.04.007","volume":"127","author":"P Agarwal","year":"2015","unstructured":"Agarwal, P., & Bhatia, R. (2015). Influence of bone marrow microenvironment on leukemic stem cells: Breaking up an intimate relationship. Advances in Cancer Research, 127, 227\u2013252. https:\/\/doi.org\/10.1016\/bs.acr.2015.04.007","journal-title":"Advances in Cancer Research"},{"key":"10069_CR44","doi-asserted-by":"publisher","unstructured":"Agarwal, P., Isringhausen, S., Li, H., Paterson, A. J., He, J., Gomariz, A., Nagasawa, T., Nombela-Arrieta, C., & Bhatia, R. (2019). Mesenchymal niche-specific expression of Cxcl12 controls quiescence of treatment-resistant leukemia stem cells. Cell Stem Cell, 24(5), 769\u2013784 e766. https:\/\/doi.org\/10.1016\/j.stem.2019.02.018","DOI":"10.1016\/j.stem.2019.02.018"},{"issue":"7487","key":"10069_CR45","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/nature12883","volume":"506","author":"A Kode","year":"2014","unstructured":"Kode, A., Manavalan, J. S., Mosialou, I., Bhagat, G., Rathinam, C. V., Luo, N., Khiabanian, H., Lee, A., Murty, V. V., Friedman, R., Brum, A., Park, D., Galili, N., Mukherjee, S., Teruya-Feldstein, J., Raza, A., Rabadan, R., Berman, E., & Kousteni, S. (2014). Leukaemogenesis induced by an activating beta-catenin mutation in osteoblasts. Nature, 506(7487), 240\u2013244. https:\/\/doi.org\/10.1038\/nature12883","journal-title":"Nature"},{"issue":"18","key":"10069_CR46","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1182\/blood-2013-07-517219","volume":"124","author":"M Krevvata","year":"2014","unstructured":"Krevvata, M., Silva, B. C., Manavalan, J. S., Galan-Diez, M., Kode, A., Matthews, B. G., Park, D., Zhang, C. A., Galili, N., Nickolas, T. L., Dempster, D. W., Dougall, W., Teruya-Feldstein, J., Economides, A. N., Kalajzic, I., Raza, A., Berman, E., Mukherjee, S., Bhagat, G., & Kousteni, S. (2014). Inhibition of leukemia cell engraftment and disease progression in mice by osteoblasts. Blood, 124(18), 2834\u20132846. https:\/\/doi.org\/10.1182\/blood-2013-07-517219","journal-title":"Blood"},{"issue":"17","key":"10069_CR47","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1182\/blood-2014-06-582924","volume":"125","author":"M Bowers","year":"2015","unstructured":"Bowers, M., Zhang, B., Ho, Y., Agarwal, P., Chen, C. C., & Bhatia, R. (2015). Osteoblast ablation reduces normal long-term hematopoietic stem cell self-renewal but accelerates leukemia development. Blood, 125(17), 2678\u20132688. https:\/\/doi.org\/10.1182\/blood-2014-06-582924","journal-title":"Blood"},{"issue":"7290","key":"10069_CR48","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/nature08851","volume":"464","author":"MH Raaijmakers","year":"2010","unstructured":"Raaijmakers, M. H., Mukherjee, S., Guo, S., Zhang, S., Kobayashi, T., Schoonmaker, J. A., Ebert, B. L., Al-Shahrour, F., Hasserjian, R. P., Scadden, E. O., Aung, Z., Matza, M., Merkenschlager, M., Lin, C., Rommens, J. M., & Scadden, D. T. (2010). Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature, 464(7290), 852\u2013857. https:\/\/doi.org\/10.1038\/nature08851","journal-title":"Nature"},{"issue":"12","key":"10069_CR49","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4000","volume":"21","author":"BG Childs","year":"2015","unstructured":"Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015). Cellular senescence in aging and age-related disease: From mechanisms to therapy. Nature Medicine, 21(12), 1424\u20131435. https:\/\/doi.org\/10.1038\/nm.4000","journal-title":"Nature Medicine"},{"issue":"20","key":"10069_CR50","doi-asserted-by":"publisher","first-page":"9363","DOI":"10.1073\/pnas.92.20.9363","volume":"92","author":"GP Dimri","year":"1995","unstructured":"Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., Pereira-Smith, O., &, et al. (1995). A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proceedings of the National Academy of Sciences of the United States of America, 92(20), 9363\u20139367. https:\/\/doi.org\/10.1073\/pnas.92.20.9363","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10069_CR51","doi-asserted-by":"publisher","unstructured":"Mammoto, T., Torisawa, Y. S., Muyleart, M., Hendee, K., Anugwom, C., Gutterman, D., & Mammoto, A. (2019). Effects of age-dependent changes in cell size on endothelial cell proliferation and senescence through YAP1. Aging, 11(17), 7051\u20137069. https:\/\/doi.org\/10.18632\/aging.102236","DOI":"10.18632\/aging.102236"},{"key":"10069_CR52","doi-asserted-by":"publisher","first-page":"645593","DOI":"10.3389\/fcell.2021.645593","volume":"9","author":"R Kumari","year":"2021","unstructured":"Kumari, R., & Jat, P. (2021). Mechanisms of cellular senescence: Cell cycle arrest and senescence associated secretory phenotype. Frontiers in Cell and Developmental Biology, 9, 645593. https:\/\/doi.org\/10.3389\/fcell.2021.645593","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"10069_CR53","doi-asserted-by":"publisher","first-page":"951574","DOI":"10.1155\/2012\/951574","volume":"2012","author":"R Mirzayans","year":"2012","unstructured":"Mirzayans, R., Andrais, B., Hansen, G., & Murray, D. (2012). Role of p16(INK4A) in Replicative Senescence and DNA Damage-induced premature senescence in p53-deficient human cells. Biochemistry Research International, 2012, 951574. https:\/\/doi.org\/10.1155\/2012\/951574","journal-title":"Biochemistry Research International"},{"issue":"6","key":"10069_CR54","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/acel.12518","volume":"15","author":"NV Petrova","year":"2016","unstructured":"Petrova, N. V., Velichko, A. K., Razin, S. V., & Kantidze, O. L. (2016). Small molecule compounds that induce cellular senescence. Aging Cell, 15(6), 999\u20131017. https:\/\/doi.org\/10.1111\/acel.12518","journal-title":"Aging Cell"},{"issue":"9","key":"10069_CR55","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1172\/jci22475","volume":"114","author":"J Krishnamurthy","year":"2004","unstructured":"Krishnamurthy, J., Torrice, C., Ramsey, M. R., Kovalev, G. I., Al-Regaiey, K., Su, L., & Sharpless, N. E. (2004). Ink4a\/Arf expression is a biomarker of aging. Journal of Clinical Investigation, 114(9), 1299\u20131307. https:\/\/doi.org\/10.1172\/jci22475","journal-title":"Journal of Clinical Investigation"},{"issue":"11","key":"10069_CR56","first-page":"2705","volume":"63","author":"IB Roninson","year":"2003","unstructured":"Roninson, I. B. (2003). Tumor cell senescence in cancer treatment. Cancer Research, 63(11), 2705\u20132715.","journal-title":"Cancer Research"},{"issue":"7501","key":"10069_CR57","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nature13193","volume":"509","author":"JM van Deursen","year":"2014","unstructured":"van Deursen, J. M. (2014). The role of senescent cells in ageing. Nature, 509(7501), 439\u2013446. https:\/\/doi.org\/10.1038\/nature13193","journal-title":"Nature"},{"issue":"11","key":"10069_CR58","first-page":"2284","volume":"55","author":"E Wang","year":"1995","unstructured":"Wang, E. (1995). Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved. Cancer Research, 55(11), 2284.","journal-title":"Cancer Research"},{"key":"10069_CR59","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.clim.2018.04.002","volume":"196","author":"D Ray","year":"2018","unstructured":"Ray, D., & Yung, R. (2018). Immune senescence, epigenetics and autoimmunity. Clinical Immunology, 196, 59\u201363. https:\/\/doi.org\/10.1016\/j.clim.2018.04.002","journal-title":"Clinical Immunology"},{"key":"10069_CR60","doi-asserted-by":"publisher","first-page":"101275","DOI":"10.1016\/j.smim.2019.04.003","volume":"40","author":"L Prata","year":"2018","unstructured":"Prata, L., Ovsyannikova, I. G., Tchkonia, T., & Kirkland, J. L. (2018). Senescent cell clearance by the immune system: Emerging therapeutic opportunities. Seminars in Immunology, 40, 101275. https:\/\/doi.org\/10.1016\/j.smim.2019.04.003","journal-title":"Seminars in Immunology"},{"key":"10069_CR61","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","volume":"5","author":"JP Coppe","year":"2010","unstructured":"Coppe, J. P., Desprez, P. Y., Krtolica, A., & Campisi, J. (2010). The senescence-associated secretory phenotype: The dark side of tumor suppression. Annual Review of Pathology, 5, 99\u2013118. https:\/\/doi.org\/10.1146\/annurev-pathol-121808-102144","journal-title":"Annual Review of Pathology"},{"issue":"5","key":"10069_CR62","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.molmed.2010.03.003","volume":"16","author":"A Freund","year":"2010","unstructured":"Freund, A., Orjalo, A. V., Desprez, P.-Y., & Campisi, J. (2010). Inflammatory networks during cellular senescence: Causes and consequences. Trends in Molecular Medicine, 16(5), 238\u2013246. https:\/\/doi.org\/10.1016\/j.molmed.2010.03.003","journal-title":"Trends in Molecular Medicine"},{"issue":"1","key":"10069_CR63","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12979-020-00187-9","volume":"17","author":"A Kale","year":"2020","unstructured":"Kale, A., Sharma, A., Stolzing, A., Desprez, P.-Y., & Campisi, J. (2020). Role of immune cells in the removal of deleterious senescent cells. Immunity & Ageing, 17(1), 16. https:\/\/doi.org\/10.1186\/s12979-020-00187-9","journal-title":"Immunity & Ageing"},{"issue":"2","key":"10069_CR64","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1093\/oxfordjournals.bmb.a072967","volume":"51","author":"FM Brennan","year":"1995","unstructured":"Brennan, F. M., Maini, R. N., & Feldmann, M. (1995). Cytokine expression in chronic inflammatory disease. British Medical Bulletin, 51(2), 368\u2013384. https:\/\/doi.org\/10.1093\/oxfordjournals.bmb.a072967","journal-title":"British Medical Bulletin"},{"key":"10069_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1322.001","volume":"1028","author":"C Caruso","year":"2004","unstructured":"Caruso, C., Lio, D., Cavallone, L., & Franceschi, C. (2004). Aging, longevity, inflammation, and cancer. Annals of the New York Academy of Sciences, 1028, 1\u201313. https:\/\/doi.org\/10.1196\/annals.1322.001","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"11","key":"10069_CR66","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s000110050632","volume":"49","author":"SA Brod","year":"2000","unstructured":"Brod, S. A. (2000). Unregulated inflammation shortens human functional longevity. Inflammation Research, 49(11), 561\u2013570. https:\/\/doi.org\/10.1007\/s000110050632","journal-title":"Inflammation Research"},{"issue":"6","key":"10069_CR67","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1182\/blood-2017-04-777029","volume":"130","author":"M Buscarlet","year":"2017","unstructured":"Buscarlet, M., Provost, S., Zada, Y. F., Barhdadi, A., Bourgoin, V., Lepine, G., Mollica, L., Szuber, N., Dube, M. P., & Busque, L. (2017). DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions. Blood, 130(6), 753\u2013762. https:\/\/doi.org\/10.1182\/blood-2017-04-777029","journal-title":"Blood"},{"issue":"12","key":"10069_CR68","doi-asserted-by":"publisher","first-page":"5465","DOI":"10.1073\/pnas.1000834107","volume":"107","author":"I Beerman","year":"2010","unstructured":"Beerman, I., Bhattacharya, D., Zandi, S., Sigvardsson, M., Weissman, I. L., Bryder, D., & Rossi, D. J. (2010). Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion. Proceedings of the National Academy of Sciences of the United States of America, 107(12), 5465\u20135470. https:\/\/doi.org\/10.1073\/pnas.1000834107","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10069_CR69","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/ni1033","volume":"5","author":"PJ Linton","year":"2004","unstructured":"Linton, P. J., & Dorshkind, K. (2004). Age-related changes in lymphocyte development and function. Nature Immunology, 5(2), 133\u2013139. https:\/\/doi.org\/10.1038\/ni1033","journal-title":"Nature Immunology"},{"issue":"8","key":"10069_CR70","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1182\/blood-2004-05-1812","volume":"104","author":"JM Guralnik","year":"2004","unstructured":"Guralnik, J. M., Eisenstaedt, R. S., Ferrucci, L., Klein, H. G., & Woodman, R. C. (2004). Prevalence of anemia in persons 65 years and older in the United States: Evidence for a high rate of unexplained anemia. Blood, 104(8), 2263\u20132268. https:\/\/doi.org\/10.1182\/blood-2004-05-1812","journal-title":"Blood"},{"issue":"1\u20133","key":"10069_CR71","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/s0047-6374(00)00137-8","volume":"117","author":"T Ogawa","year":"2000","unstructured":"Ogawa, T., Kitagawa, M., & Hirokawa, K. (2000). Age-related changes of human bone marrow: A histometric estimation of proliferative cells, apoptotic cells, T cells, B cells and macrophages. Mechanisms of Ageing and Development, 117(1\u20133), 57\u201368. https:\/\/doi.org\/10.1016\/s0047-6374(00)00137-8","journal-title":"Mechanisms of Ageing and Development"},{"key":"10069_CR72","doi-asserted-by":"publisher","unstructured":"Bousounis, P., Bergo, V., & Trompouki, E. (2021). Inflammation, aging and hematopoiesis: a complex relationship. Cells, 10(6), 1386. https:\/\/doi.org\/10.3390\/cells10061386","DOI":"10.3390\/cells10061386"},{"issue":"11","key":"10069_CR73","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1182\/blood-2011-11-391730","volume":"119","author":"AV Ergen","year":"2012","unstructured":"Ergen, A. V., Boles, N. C., & Goodell, M. A. (2012). Rantes\/Ccl5 influences hematopoietic stem cell subtypes and causes myeloid skewing. Blood, 119(11), 2500\u20132509. https:\/\/doi.org\/10.1182\/blood-2011-11-391730","journal-title":"Blood"},{"issue":"2","key":"10069_CR74","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3324\/haematol.2014.109769","volume":"100","author":"Y Zhao","year":"2015","unstructured":"Zhao, Y., Wu, D., Fei, C., Guo, J., Gu, S., Zhu, Y., Xu, F., Zhang, Z., Wu, L., Li, X., & Chang, C. (2015). Down-regulation of Dicer1 promotes cellular senescence and decreases the differentiation and stem cell-supporting capacities of mesenchymal stromal cells in patients with myelodysplastic syndrome. Haematologica, 100(2), 194\u2013204. https:\/\/doi.org\/10.3324\/haematol.2014.109769","journal-title":"Haematologica"},{"issue":"5","key":"10069_CR75","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41419-018-0545-6","volume":"9","author":"J Guo","year":"2018","unstructured":"Guo, J., Zhao, Y., Fei, C., Zhao, S., Zheng, Q., Su, J., Wu, D., Li, X., & Chang, C. (2018). Dicer1 downregulation by multiple myeloma cells promotes the senescence and tumor-supporting capacity and decreases the differentiation potential of mesenchymal stem cells. Cell Death & Disease, 9(5), 512. https:\/\/doi.org\/10.1038\/s41419-018-0545-6","journal-title":"Cell Death & Disease"},{"issue":"50","key":"10069_CR76","doi-asserted-by":"publisher","first-page":"20012","DOI":"10.1073\/pnas.1116110108","volume":"108","author":"WW Pang","year":"2011","unstructured":"Pang, W. W., Price, E. A., Sahoo, D., Beerman, I., Maloney, W. J., Rossi, D. J., Schrier, S. L., & Weissman, I. L. (2011). Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proceedings of the National Academy of Sciences of the United States of America, 108(50), 20012\u201320017. https:\/\/doi.org\/10.1073\/pnas.1116110108","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"12","key":"10069_CR77","doi-asserted-by":"publisher","first-page":"13285","DOI":"10.18632\/oncotarget.7690","volume":"7","author":"K O'Hagan-Wong","year":"2016","unstructured":"O\u2019Hagan-Wong, K., Nadeau, S., Carrier-Leclerc, A., Apablaza, F., Hamdy, R., Shum-Tim, D., Rodier, F., & Colmegna, I. (2016). Increased IL-6 secretion by aged human mesenchymal stromal cells disrupts hematopoietic stem and progenitor cells\u2019 homeostasis. Oncotarget, 7(12), 13285\u201313296. https:\/\/doi.org\/10.18632\/oncotarget.7690","journal-title":"Oncotarget"},{"key":"10069_CR78","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.stem.2015.05.002","volume":"16","author":"Peter D. Adams","year":"2015","unstructured":"Adams, P. D., Jasper, H., & Rudolph, K. L. (2015). Aging-induced stem cell mutations as drivers for disease and cancer. Cell Stem Cell, 16, 601\u2013612. https:\/\/doi.org\/10.1016\/j.stem.2015.05.002","journal-title":"Cell Stem Cell"},{"issue":"15","key":"10069_CR79","doi-asserted-by":"publisher","first-page":"6734","DOI":"10.1158\/0008-5472.CAN-05-0703","volume":"65","author":"KK Tsai","year":"2005","unstructured":"Tsai, K. K., Chuang, E. Y., Little, J. B., & Yuan, Z. M. (2005). Cellular mechanisms for low-dose ionizing radiation-induced perturbation of the breast tissue microenvironment. Cancer Research, 65(15), 6734\u20136744. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-0703","journal-title":"Cancer Research"},{"issue":"2","key":"10069_CR80","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1158\/0008-5472.CAN-05-1716","volume":"66","author":"C Bavik","year":"2006","unstructured":"Bavik, C., Coleman, I., Dean, J. P., Knudsen, B., Plymate, S., & Nelson, P. S. (2006). The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Cancer Research, 66(2), 794\u2013802. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-1716","journal-title":"Cancer Research"},{"issue":"1","key":"10069_CR81","doi-asserted-by":"publisher","first-page":"15729","DOI":"10.1038\/ncomms15728","volume":"8","author":"M Takasugi","year":"2017","unstructured":"Takasugi, M., Okada, R., Takahashi, A., Virya Chen, D., Watanabe, S., & Hara, E. (2017). Small extracellular vesicles secreted from senescent cells promote cancer cell proliferation through EphA2. Nature Communications, 8(1), 15729. https:\/\/doi.org\/10.1038\/ncomms15728","journal-title":"Nature Communications"},{"key":"10069_CR82","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13578-015-0012-3","volume":"5","author":"Y Li","year":"2015","unstructured":"Li, Y., Xu, X., Wang, L., Liu, G., Li, Y., Wu, X., Jing, Y., Li, H., & Wang, G. (2015). Senescent mesenchymal stem cells promote colorectal cancer cells growth via galectin-3 expression. Cell & Bioscience, 5, 21. https:\/\/doi.org\/10.1186\/s13578-015-0012-3","journal-title":"Cell & Bioscience"},{"issue":"3","key":"10069_CR83","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1101\/gad.271882.115","volume":"30","author":"BC Capell","year":"2016","unstructured":"Capell, B. C., Drake, A. M., Zhu, J., Shah, P. P., Dou, Z., Dorsey, J., Simola, D. F., Donahue, G., Sammons, M., Rai, T. S., Natale, C., Ridky, T. W., Adams, P. D., & Berger, S. L. (2016). MLL1 is essential for the senescence-associated secretory phenotype. Genes and Development, 30(3), 321\u2013336. https:\/\/doi.org\/10.1101\/gad.271882.115","journal-title":"Genes and Development"},{"issue":"12","key":"10069_CR84","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1371\/journal.pbio.0060301","volume":"6","author":"JP Coppe","year":"2008","unstructured":"Coppe, J. P., Patil, C. K., Rodier, F., Sun, Y., Munoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P. Y., & Campisi, J. (2008). Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biology, 6(12), 2853\u20132868. https:\/\/doi.org\/10.1371\/journal.pbio.0060301","journal-title":"PLoS Biology"},{"issue":"2","key":"10069_CR85","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/criticalvalues\/2.2.30","volume":"2","author":"JR Krause","year":"2009","unstructured":"Krause, J. R. (2009). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues: An Overview. Critical Values, 2(2), 30\u201332. https:\/\/doi.org\/10.1093\/criticalvalues\/2.2.30","journal-title":"Critical Values"},{"issue":"9","key":"10069_CR86","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1038\/leu.2013.193","volume":"27","author":"S Geyh","year":"2013","unstructured":"Geyh, S., Oz, S., Cadeddu, R. P., Frobel, J., Bruckner, B., Kundgen, A., Fenk, R., Bruns, I., Zilkens, C., Hermsen, D., Gattermann, N., Kobbe, G., Germing, U., Lyko, F., Haas, R., & Schroeder, T. (2013). Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells. Leukemia, 27(9), 1841\u20131851. https:\/\/doi.org\/10.1038\/leu.2013.193","journal-title":"Leukemia"},{"issue":"11","key":"10069_CR87","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1038\/leu.2014.197","volume":"28","author":"A Poloni","year":"2014","unstructured":"Poloni, A., Maurizi, G., Mattiucci, D., Amatori, S., Fogliardi, B., Costantini, B., Mariani, M., Mancini, S., Olivieri, A., Fanelli, M., & Leoni, P. (2014). Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes. Leukemia, 28(11), 2241\u20132244. https:\/\/doi.org\/10.1038\/leu.2014.197","journal-title":"Leukemia"},{"key":"10069_CR88","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/leu.2008.361","volume":"23","author":"O Lopez-Villar","year":"2009","unstructured":"Lopez-Villar, O., Garcia, J. L., Sanchez-Guijo, F. M., Robledo, C., Villaron, E. M., Hern\u00e1ndez-Campo, P., Lopez-Holgado, N., Diez-Campelo, M., Barbado, M. V., Perez-Simon, J. A., Hern\u00e1ndez-Rivas, J. M., San-Miguel, J. F., & del Ca\u00f1izo, M. C. (2009). Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q\u2212 syndrome. Leukemia, 23, 664. https:\/\/doi.org\/10.1038\/leu.2008.361","journal-title":"Leukemia"},{"issue":"10","key":"10069_CR89","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1089\/scd.2011.0390","volume":"21","author":"CM Aanei","year":"2012","unstructured":"Aanei, C. M., Flandrin, P., Eloae, F. Z., Carasevici, E., Guyotat, D., Wattel, E., & Campos, L. (2012). Intrinsic growth deficiencies of mesenchymal stromal cells in myelodysplastic syndromes. Stem Cells and Development, 21(10), 1604\u20131615. https:\/\/doi.org\/10.1089\/scd.2011.0390","journal-title":"Stem Cells and Development"},{"issue":"6","key":"10069_CR90","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/ejh.12385","volume":"93","author":"C Fei","year":"2014","unstructured":"Fei, C., Zhao, Y., Guo, J., Gu, S., Li, X., & Chang, C. (2014). Senescence of bone marrow mesenchymal stromal cells is accompanied by activation of p53\/p21 pathway in myelodysplastic syndromes. European Journal of Haematology, 93(6), 476\u2013486. https:\/\/doi.org\/10.1111\/ejh.12385","journal-title":"European Journal of Haematology"},{"issue":"5","key":"10069_CR91","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3324\/haematol.2017.172429","volume":"103","author":"SM Kornblau","year":"2018","unstructured":"Kornblau, S. M., Ruvolo, P. P., Wang, R. Y., Battula, V. L., Shpall, E. J., Ruvolo, V. R., McQueen, T., Qui, Y., Zeng, Z., Pierce, S., Jacamo, R., Yoo, S. Y., Le, P. M., Sun, J., Hail, N., Jr., Konopleva, M., & Andreeff, M. (2018). Distinct protein signatures of acute myeloid leukemia bone marrow-derived stromal cells are prognostic for patient survival. Haematologica, 103(5), 810\u2013821. https:\/\/doi.org\/10.3324\/haematol.2017.172429","journal-title":"Haematologica"},{"issue":"4","key":"10069_CR92","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.leukres.2015.01.013","volume":"39","author":"P Chandran","year":"2015","unstructured":"Chandran, P., Le, Y., Li, Y., Sabloff, M., Mehic, J., Rosu-Myles, M., & Allan, D. S. (2015). Mesenchymal stromal cells from patients with acute myeloid leukemia have altered capacity to expand differentiated hematopoietic progenitors. Leukemia Research, 39(4), 486\u2013493. https:\/\/doi.org\/10.1016\/j.leukres.2015.01.013","journal-title":"Leukemia Research"},{"issue":"5","key":"10069_CR93","doi-asserted-by":"publisher","first-page":"e12819","DOI":"10.1111\/cpr.12819","volume":"53","author":"H Choi","year":"2020","unstructured":"Choi, H., Kim, Y., Kang, D., Kwon, A., Kim, J., Min Kim, J., Park, S. S., Kim, Y. J., Min, C. K., & Kim, M. (2020). Common and different alterations of bone marrow mesenchymal stromal cells in myelodysplastic syndrome and multiple myeloma. Cell Proliferation, 53(5), e12819. https:\/\/doi.org\/10.1111\/cpr.12819","journal-title":"Cell Proliferation"},{"issue":"3","key":"10069_CR94","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/leu.2015.325","volume":"30","author":"S Geyh","year":"2016","unstructured":"Geyh, S., Rodr\u00edguez-Paredes, M., J\u00e4ger, P., Khandanpour, C., Cadeddu, R. P., Gutekunst, J., Wilk, C. M., Fenk, R., Zilkens, C., Hermsen, D., Germing, U., Kobbe, G., Lyko, F., Haas, R., & Schroeder, T. (2016). Functional inhibition of mesenchymal stromal cells in acute myeloid leukemia. Leukemia, 30(3), 683\u2013691. https:\/\/doi.org\/10.1038\/leu.2015.325","journal-title":"Leukemia"},{"key":"10069_CR95","doi-asserted-by":"publisher","unstructured":"Falconi, G., Fabiani, E., Fianchi, L., Criscuolo, M., Raffaelli, C. S., Bellesi, S., Hohaus, S., Voso, M. T., D'Alo, F., & Leone, G. (2016). Impairment of PI3K\/AKT and WNT\/beta-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes. Experimental Hematology, 44(1), 75\u201383 e71\u201374, https:\/\/doi.org\/10.1016\/j.exphem.2015.10.005","DOI":"10.1016\/j.exphem.2015.10.005"},{"issue":"6","key":"10069_CR96","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/s41375-018-0310-y","volume":"33","author":"Z Poon","year":"2019","unstructured":"Poon, Z., Dighe, N., Venkatesan, S. S., Cheung, A. M. S., Fan, X., Bari, S., Hota, M., Ghosh, S., & Hwang, W. Y. K. (2019). Bone marrow MSCs in MDS: Contribution towards dysfunctional hematopoiesis and potential targets for disease response to hypomethylating therapy. Leukemia, 33(6), 1487\u20131500. https:\/\/doi.org\/10.1038\/s41375-018-0310-y","journal-title":"Leukemia"},{"issue":"1","key":"10069_CR97","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.htct.2019.12.0","volume":"43","author":"M Boada","year":"2021","unstructured":"Boada, M., Echarte, L., Guillermo, C., Diaz, L., Touri\u00f1o, C., & Grille, S. (2021). 5-Azacytidine restores interleukin 6-increased production in mesenchymal stromal cells from myelodysplastic patients. Hematology, Transfusion and Cell Therapy, 43(1), 35\u201342. https:\/\/doi.org\/10.1016\/j.htct.2019.12.0","journal-title":"Hematology, Transfusion and Cell Therapy"},{"key":"10069_CR98","doi-asserted-by":"publisher","first-page":"40707","DOI":"10.1038\/srep40707","volume":"7","author":"MR Lopes","year":"2017","unstructured":"Lopes, M. R., Pereira, J. K., de Melo Campos, P., Machado-Neto, J. A., Traina, F., Saad, S. T., & Favaro, P. (2017). De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes. Scientific Reports, 7, 40707. https:\/\/doi.org\/10.1038\/srep40707","journal-title":"Scientific Reports"},{"issue":"5","key":"10069_CR99","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/leu.2016.324","volume":"31","author":"EK von der Heide","year":"2017","unstructured":"von der Heide, E. K., Neumann, M., Vosberg, S., James, A. R., Schroeder, M. P., Ortiz-Tanchez, J., Isaakidis, K., Schlee, C., Luther, M., Johrens, K., Anagnostopoulos, I., Mochmann, L. H., Nowak, D., Hofmann, W. K., Greif, P. A., & Baldus, C. D. (2017). Molecular alterations in bone marrow mesenchymal stromal cells derived from acute myeloid leukemia patients. Leukemia, 31(5), 1069\u20131078. https:\/\/doi.org\/10.1038\/leu.2016.324","journal-title":"Leukemia"},{"issue":"4","key":"10069_CR100","doi-asserted-by":"publisher","first-page":"4755","DOI":"10.1096\/fj.201801931R","volume":"33","author":"J Cheng","year":"2019","unstructured":"Cheng, J., Li, Y., Liu, S., Jiang, Y., Ma, J., Wan, L., Li, Q., & Pang, T. (2019). CXCL8 derived from mesenchymal stromal cells supports survival and proliferation of acute myeloid leukemia cells through the PI3K\/AKT pathway. The Federation of American Societies of Experimental Biology Journal, 33(4), 4755\u20134764. https:\/\/doi.org\/10.1096\/fj.201801931R","journal-title":"The Federation of American Societies of Experimental Biology Journal"},{"issue":"4","key":"10069_CR101","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/leu.2011.251","volume":"26","author":"A Pardanani","year":"2012","unstructured":"Pardanani, A., Finke, C., Lasho, T. L., Al-Kali, A., Begna, K. H., Hanson, C. A., & Tefferi, A. (2012). IPSS-independent prognostic value of plasma CXCL10, IL-7 and IL-6 levels in myelodysplastic syndromes. Leukemia, 26(4), 693\u2013699. https:\/\/doi.org\/10.1038\/leu.2011.251","journal-title":"Leukemia"},{"issue":"22","key":"10069_CR102","doi-asserted-by":"publisher","first-page":"e15844","DOI":"10.1097\/MD.0000000000015844","volume":"98","author":"X Shi","year":"2019","unstructured":"Shi, X., Zheng, Y., Xu, L., Cao, C., Dong, B., & Chen, X. (2019). The inflammatory cytokine profile of myelodysplastic syndromes: A meta-analysis. Medicine (Baltimore), 98(22), e15844. https:\/\/doi.org\/10.1097\/MD.0000000000015844","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10069_CR103","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1089\/scd.2016.0295","volume":"26","author":"L Desbourdes","year":"2017","unstructured":"Desbourdes, L., Javary, J., Charbonnier, T., Ishac, N., Bourgeais, J., Iltis, A., Chomel, J. C., Turhan, A., Guilloton, F., Tarte, K., Demattei, M. V., Ducrocq, E., Rouleux-Bonnin, F., Gyan, E., Herault, O., & Domenech, J. (2017). Alteration analysis of bone marrow mesenchymal stromal cells from de novo acute myeloid leukemia patients at diagnosis. Stem Cells and Development, 26(10), 709\u2013722. https:\/\/doi.org\/10.1089\/scd.2016.0295","journal-title":"Stem Cells and Development"},{"issue":"5","key":"10069_CR104","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1182\/blood-2018-04-845420","volume":"133","author":"AM Abdul-Aziz","year":"2019","unstructured":"Abdul-Aziz, A. M., Sun, Y., Hellmich, C., Marlein, C. R., Mistry, J., Forde, E., Piddock, R. E., Shafat, M. S., Morfakis, A., Mehta, T., Di Palma, F., Macaulay, I., Ingham, C. J., Haestier, A., Collins, A., Campisi, J., Bowles, K. M., & Rushworth, S. A. (2019). Acute myeloid leukemia induces protumoral p16INK4a-driven senescence in the bone marrow microenvironment. Blood, 133(5), 446\u2013456. https:\/\/doi.org\/10.1182\/blood-2018-04-845420","journal-title":"Blood"},{"key":"10069_CR105","doi-asserted-by":"publisher","first-page":"547430","DOI":"10.1155\/2013\/547430","volume":"2013","author":"YC Su","year":"2013","unstructured":"Su, Y. C., Li, S. C., Wu, Y. C., Wang, L. M., Chao, K. S., & Liao, H. F. (2013). Resveratrol downregulates interleukin-6-stimulated sonic hedgehog signaling in human acute myeloid leukemia. Evidence-Based Complementary and Alternative Medicine, 2013, 547430. https:\/\/doi.org\/10.1155\/2013\/547430","journal-title":"Evidence-Based Complementary and Alternative Medicine"},{"issue":"3","key":"10069_CR106","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.1600-0609.1998.tb01083.x","volume":"61","author":"M Saily","year":"1998","unstructured":"Saily, M., Koistinen, P., Zheng, A., & Savolainen, E. R. (1998). Signaling through interleukin-6 receptor supports blast cell proliferation in acute myeloblastic leukemia. European Journal of Haematology, 61(3), 190\u2013196. https:\/\/doi.org\/10.1111\/j.1600-0609.1998.tb01083.x","journal-title":"European Journal of Haematology"},{"issue":"2","key":"10069_CR107","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1158\/0008-5472.CAN-16-1095","volume":"77","author":"AM Abdul-Aziz","year":"2017","unstructured":"Abdul-Aziz, A. M., Shafat, M. S., Mehta, T. K., Di Palma, F., Lawes, M. J., Rushworth, S. A., & Bowles, K. M. (2017). MIF-Induced Stromal PKCbeta\/IL8 Is Essential in Human Acute Myeloid Leukemia. Cancer Research, 77(2), 303\u2013311. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-1095","journal-title":"Cancer Research"},{"issue":"12","key":"10069_CR108","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","volume":"111","author":"Hallek, M., Cheson, B. D., Catovsky, D., Caligaris-Cappio, F., Dighiero, G., Dohner, H., Hillmen, P., Keating, M. J., Montserrat, E., Rai, K. R., Kipps, T. J., & International Workshop on Chronic Lymphocytic, L","year":"2008","unstructured":"Hallek, M., Cheson, B. D., Catovsky, D., Caligaris-Cappio, F., Dighiero, G., Dohner, H., Hillmen, P., Keating, M. J., Montserrat, E., Rai, K. R., Kipps, T. J., & International Workshop on Chronic Lymphocytic, L. (2008). Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: A report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood, 111(12), 5446\u20135456. https:\/\/doi.org\/10.1182\/blood-2007-06-093906","journal-title":"Blood"},{"issue":"9","key":"10069_CR109","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1089\/scd.2012.0255","volume":"22","author":"C Pontikoglou","year":"2013","unstructured":"Pontikoglou, C., Kastrinaki, M. C., Klaus, M., Kalpadakis, C., Katonis, P., Alpantaki, K., Pangalis, G. A., & Papadaki, H. A. (2013). Study of the quantitative, functional, cytogenetic, and immunoregulatory properties of bone marrow mesenchymal stem cells in patients with B-cell chronic lymphocytic leukemia. Stem Cells and Development, 22(9), 1329\u20131341. https:\/\/doi.org\/10.1089\/scd.2012.0255","journal-title":"Stem Cells and Development"},{"issue":"24","key":"10069_CR110","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1089\/scd.2014.0229","volume":"23","author":"A Janel","year":"2014","unstructured":"Janel, A., Dubois-Galopin, F., Bourgne, C., Berger, J., Tarte, K., Boiret-Dupre, N., Boisgard, S., Verrelle, P., Dechelotte, P., Tournilhac, O., & Berger, M. G. (2014). The chronic lymphocytic leukemia clone disrupts the bone marrow microenvironment. Stem Cells and Development, 23(24), 2972\u20132982. https:\/\/doi.org\/10.1089\/scd.2014.0229","journal-title":"Stem Cells and Development"},{"issue":"7","key":"10069_CR111","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.leukres.2006.11.024","volume":"31","author":"NE Kay","year":"2007","unstructured":"Kay, N. E., Shanafelt, T. D., Strege, A. K., Lee, Y. K., Bone, N. D., & Raza, A. (2007). Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an \u201cangiogenic switch.\u201d Leukemia Research, 31(7), 899\u2013906. https:\/\/doi.org\/10.1016\/j.leukres.2006.11.024","journal-title":"Leukemia Research"},{"issue":"1","key":"10069_CR112","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1182\/blood.v97.1.256","volume":"97","author":"L Fayad","year":"2001","unstructured":"Fayad, L., Keating, M. J., Reuben, J. M., O\u2019Brien, S., Lee, B. N., Lerner, S., & Kurzrock, R. (2001). Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: Correlation with phenotypic characteristics and outcome. Blood, 97(1), 256\u2013263. https:\/\/doi.org\/10.1182\/blood.v97.1.256","journal-title":"Blood"},{"issue":"3","key":"10069_CR113","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1046\/j.1365-2141.1999.01752.x","volume":"107","author":"S Molica","year":"1999","unstructured":"Molica, S., Vitelli, G., Levato, D., Gandolfo, G. M., & Liso, V. (1999). Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukaemia. British Journal of Haematology, 107(3), 605\u2013610. https:\/\/doi.org\/10.1046\/j.1365-2141.1999.01752.x","journal-title":"British Journal of Haematology"},{"issue":"3","key":"10069_CR114","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1046\/j.1365-2141.2003.04118.x","volume":"120","author":"WG Wierda","year":"2003","unstructured":"Wierda, W. G., Johnson, M. M., Do, K. A., Manshouri, T., Dey, A., O\u2019Brien, S., Giles, F. J., Kantarjian, H., Thomas, D., Faderl, S., Lerner, S., Keating, M., & Albitar, M. (2003). Plasma interleukin 8 level predicts for survival in chronic lymphocytic leukaemia. British Journal of Haematology, 120(3), 452\u2013456. https:\/\/doi.org\/10.1046\/j.1365-2141.2003.04118.x","journal-title":"British Journal of Haematology"},{"issue":"9","key":"10069_CR115","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.3109\/10428194.2012.666662","volume":"53","author":"JY Yoon","year":"2012","unstructured":"Yoon, J. Y., Lafarge, S., Dawe, D., Lakhi, S., Kumar, R., Morales, C., Marshall, A., Gibson, S. B., & Johnston, J. B. (2012). Association of interleukin-6 and interleukin-8 with poor prognosis in elderly patients with chronic lymphocytic leukemia. Leukemia and Lymphoma, 53(9), 1735\u20131742. https:\/\/doi.org\/10.3109\/10428194.2012.666662","journal-title":"Leukemia and Lymphoma"},{"issue":"5","key":"10069_CR116","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/cncr.10772","volume":"95","author":"R Lai","year":"2002","unstructured":"Lai, R., O\u2019Brien, S., Maushouri, T., Rogers, A., Kantarjian, H., Keating, M., & Albitar, M. (2002). Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia. Cancer, 95(5), 1071\u20131075. https:\/\/doi.org\/10.1002\/cncr.10772","journal-title":"Cancer"},{"issue":"4","key":"10069_CR117","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1182\/blood.V100.4.1215.h81602001215_1215_1219","volume":"100","author":"A Ferrajoli","year":"2002","unstructured":"Ferrajoli, A., Keating, M. J., Manshouri, T., Giles, F. J., Dey, A., Estrov, Z., Koller, C. A., Kurzrock, R., Thomas, D. A., Faderl, S., Lerner, S., O\u2019Brien, S., & Albitar, M. (2002). The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemia. Blood, 100(4), 1215\u20131219.\u00a0https:\/\/doi.org\/10.1182\/blood.V100.4.1215.h81602001215_1215_1219","journal-title":"Blood"},{"key":"10069_CR118","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.leukres.2018.01.006","volume":"66","author":"F Zhu","year":"2018","unstructured":"Zhu, F., McCaw, L., Spaner, D. E., & Gorczynski, R. M. (2018). Targeting the IL-17\/IL-6 axis can alter growth of chronic lymphocytic leukemia in vivo\/in vitro. Leukemia Research, 66, 28\u201338. https:\/\/doi.org\/10.1016\/j.leukres.2018.01.006","journal-title":"Leukemia Research"},{"issue":"1","key":"10069_CR119","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1046\/j.1365-2141.1996.00305.x","volume":"92","author":"P Panayiotidis","year":"1996","unstructured":"Panayiotidis, P., Jones, D., Ganeshaguru, K., Foroni, L., & Hoffbrand, A. V. (1996). Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. British Journal of Haematology, 92(1), 97\u2013103. https:\/\/doi.org\/10.1046\/j.1365-2141.1996.00305.x","journal-title":"British Journal of Haematology"},{"issue":"39","key":"10069_CR120","doi-asserted-by":"publisher","first-page":"42130","DOI":"10.18632\/oncotarget.6239","volume":"6","author":"V Trimarco","year":"2015","unstructured":"Trimarco, V., Ave, E., Facco, M., Chiodin, G., Frezzato, F., Martini, V., Gattazzo, C., Lessi, F., Giorgi, C. A., Visentin, A., Castelli, M., Severin, F., Zambello, R., Piazza, F., Semenzato, G., & Trentin, L. (2015). Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival. Oncotarget, 6(39), 42130\u201342149. https:\/\/doi.org\/10.18632\/oncotarget.6239","journal-title":"Oncotarget"},{"issue":"9","key":"10069_CR121","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.3324\/haematol.2016.163337","volume":"102","author":"E Crompot","year":"2017","unstructured":"Crompot, E., Van Damme, M., Pieters, K., Vermeersch, M., Perez-Morga, D., Mineur, P., Maerevoet, M., Meuleman, N., Bron, D., Lagneaux, L., & Stamatopoulos, B. (2017). Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B cells from apoptosis, enhance their migration and induce gene expression modifications. Haematologica, 102(9), 1594\u20131604. https:\/\/doi.org\/10.3324\/haematol.2016.163337","journal-title":"Haematologica"},{"issue":"7\u20138","key":"10069_CR122","doi-asserted-by":"publisher","first-page":"619","DOI":"10.2119\/molmed.2010.00210","volume":"17","author":"I Gehrke","year":"2011","unstructured":"Gehrke, I., Gandhirajan, R. K., Poll-Wolbeck, S. J., Hallek, M., & Kreuzer, K. A. (2011). Bone marrow stromal cell-derived vascular endothelial growth factor (VEGF) rather than chronic lymphocytic leukemia (CLL) cell-derived VEGF is essential for the apoptotic resistance of cultured CLL cells. Molecular Medicine, 17(7\u20138), 619\u2013627. https:\/\/doi.org\/10.2119\/molmed.2010.00210","journal-title":"Molecular Medicine"},{"issue":"3","key":"10069_CR123","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1182\/blood-2003-08-2763","volume":"104","author":"YK Lee","year":"2004","unstructured":"Lee, Y. K., Bone, N. D., Strege, A. K., Shanafelt, T. D., Jelinek, D. F., & Kay, N. E. (2004). VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG). B-cell chronic lymphocytic leukemia. Blood, 104(3), 788\u2013794. https:\/\/doi.org\/10.1182\/blood-2003-08-2763","journal-title":"B-cell chronic lymphocytic leukemia. Blood"},{"issue":"13","key":"10069_CR124","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1158\/1078-0432.CCR-10-0232","volume":"16","author":"J Paesler","year":"2010","unstructured":"Paesler, J., Gehrke, I., Gandhirajan, R. K., Filipovich, A., Hertweck, M., Erdfelder, F., Uhrmacher, S., Poll-Wolbeck, S. J., Hallek, M., & Kreuzer, K. A. (2010). The vascular endothelial growth factor receptor tyrosine kinase inhibitors vatalanib and pazopanib potently induce apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo. Clinical Cancer Research, 16(13), 3390\u20133398. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-0232","journal-title":"Clinical Cancer Research"},{"issue":"10","key":"10069_CR125","doi-asserted-by":"publisher","first-page":"4382","DOI":"10.1182\/blood.V87.10.4382.bloodjournal87104382","volume":"87","author":"P Francia di Celle","year":"1996","unstructured":"Francia di Celle, P., Mariani, S., Riera, L., Stacchini, A., Reato, G., & Foa, R. (1996). Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion. Blood, 87(10), 4382\u20134389. https:\/\/doi.org\/10.1182\/blood.V87.10.4382.bloodjournal87104382","journal-title":"Blood"},{"key":"10069_CR126","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.exphem.2020.12.007","volume":"95","author":"G Blanco","year":"2021","unstructured":"Blanco, G., Puiggros, A., Sherry, B., Nonell, L., Calvo, X., Puigdecanet, E., Chiu, P. Y., Kieso, Y., Ferrer, G., Palacios, F., Arnal, M., Rodriguez-Rivera, M., Gimeno, E., Abella, E., Rai, K. R., Abrisqueta, P., Bosch, F., Calon, A., Ferrer, A., Chiorazzi, N., et al. (2021). Chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemia. Experimental Hematology, 95, 68\u201380. https:\/\/doi.org\/10.1016\/j.exphem.2020.12.007","journal-title":"Experimental Hematology"},{"issue":"6\u20137","key":"10069_CR127","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/0145-2126(92)90009-v","volume":"16","author":"M Aguilar-Santelises","year":"1992","unstructured":"Aguilar-Santelises, M., Loftenius, A., Ljungh, C., Svenson, S. B., Andersson, B., Mellstedt, H., & Jondal, M. (1992). Serum levels of helper factors (IL-1\u03b1, IL-1\u03b2 and IL-6), T-cell products (sCD4 and sCD8), sIL-2R and \u03b22-microglobulin in patients with B-CLL and benign B lymphocytosis. Leukemia Research, 16(6\u20137), 607\u2013613. https:\/\/doi.org\/10.1016\/0145-2126(92)90009-v","journal-title":"Leukemia Research"},{"issue":"12","key":"10069_CR128","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar, S. V., Dimopoulos, M. A., Palumbo, A., Blade, J., Merlini, G., Mateos, M. V., Kumar, S., Hillengass, J., Kastritis, E., Richardson, P., Landgren, O., Paiva, B., Dispenzieri, A., Weiss, B., LeLeu, X., Zweegman, S., Lonial, S., Rosinol, L., Zamagni, E., Jagannath, S., et al. (2014). International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncology, 15(12), e538-548. https:\/\/doi.org\/10.1016\/S1470-2045(14)70442-5","journal-title":"Lancet Oncology"},{"issue":"3","key":"10069_CR129","doi-asserted-by":"publisher","first-page":"e59756","DOI":"10.1371\/journal.pone.0059756","volume":"8","author":"T Andre","year":"2013","unstructured":"Andre, T., Meuleman, N., Stamatopoulos, B., De Bruyn, C., Pieters, K., Bron, D., & Lagneaux, L. (2013). Evidences of early senescence in multiple myeloma bone marrow mesenchymal stromal cells. PLoS ONE, 8(3), e59756. https:\/\/doi.org\/10.1371\/journal.pone.0059756","journal-title":"PLoS ONE"},{"issue":"10","key":"10069_CR130","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1080\/10428190701593644","volume":"48","author":"L Garderet","year":"2007","unstructured":"Garderet, L., Mazurier, C., Chapel, A., Ernou, I., Boutin, L., Holy, X., Gorin, N. C., Lopez, M., Doucet, C., & Lataillade, J. J. (2007). Mesenchymal stem cell abnormalities in patients with multiple myeloma. Leukemia Lymphoma, 48(10), 2032\u20132041. https:\/\/doi.org\/10.1080\/10428190701593644","journal-title":"Leukemia Lymphoma"},{"issue":"12","key":"10069_CR131","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1038\/leu.2012.126","volume":"26","author":"S Xu","year":"2012","unstructured":"Xu, S., Evans, H., Buckle, C., De Veirman, K., Hu, J., Xu, D., Menu, E., De Becker, A., Vande Broek, I., Leleu, X., Camp, B. V., Croucher, P., Vanderkerken, K., & Van Riet, I. (2012). Impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients is associated with a blockade in the deactivation of the Notch signaling pathway. Leukemia, 26(12), 2546\u20132549. https:\/\/doi.org\/10.1038\/leu.2012.126","journal-title":"Leukemia"},{"issue":"5","key":"10069_CR132","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/sj.leu.2404621","volume":"21","author":"J Corre","year":"2007","unstructured":"Corre, J., Mahtouk, K., Attal, M., Gadelorge, M., Huynh, A., Fleury-Cappellesso, S., Danho, C., Laharrague, P., Klein, B., Reme, T., & Bourin, P. (2007). Bone marrow mesenchymal stem cells are abnormal in multiple myeloma. Leukemia, 21(5), 1079\u20131088. https:\/\/doi.org\/10.1038\/sj.leu.2404621","journal-title":"Leukemia"},{"issue":"33","key":"10069_CR133","doi-asserted-by":"publisher","first-page":"55405","DOI":"10.18632\/oncotarget.19265","volume":"8","author":"J Guo","year":"2017","unstructured":"Guo, J., Fei, C., Zhao, Y., Zhao, S., Zheng, Q., Su, J., Wu, D., Li, X., & Chang, C. (2017). Lenalidomide restores the osteogenic differentiation of bone marrow mesenchymal stem cells from multiple myeloma patients via deactivating Notch signaling pathway. Oncotarget, 8(33), 55405\u201355421. https:\/\/doi.org\/10.18632\/oncotarget.19265","journal-title":"Oncotarget"},{"issue":"4","key":"10069_CR134","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/bjh.15669","volume":"184","author":"SJ Mehdi","year":"2019","unstructured":"Mehdi, S. J., Johnson, S. K., Epstein, J., Zangari, M., Qu, P., Hoering, A., van Rhee, F., Schinke, C., Thanendrarajan, S., Barlogie, B., Davies, F. E., Morgan, G. J., & Yaccoby, S. (2019). Mesenchymal stem cells gene signature in high-risk myeloma bone marrow linked to suppression of distinct IGFBP2-expressing small adipocytes. British Journal of Haematology, 184(4), 578\u2013593. https:\/\/doi.org\/10.1111\/bjh.15669","journal-title":"British Journal of Haematology"},{"issue":"1","key":"10069_CR135","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12885-015-1078-3","volume":"15","author":"R Berenstein","year":"2015","unstructured":"Berenstein, R., Blau, O., Nogai, A., Waechter, M., Slonova, E., Schmidt-Hieber, M., Kunitz, A., Pezzutto, A., Doerken, B., & Blau, I. W. (2015). Multiple myeloma cells alter the senescence phenotype of bone marrow mesenchymal stromal cells under participation of the DLK1-DIO3 genomic region. BMC Cancer, 15(1), 68. https:\/\/doi.org\/10.1186\/s12885-015-1078-3","journal-title":"BMC Cancer"},{"key":"10069_CR136","doi-asserted-by":"publisher","first-page":"584683","DOI":"10.3389\/fonc.2020.584683","volume":"10","author":"H Fairfield","year":"2020","unstructured":"Fairfield, H., Costa, S., Falank, C., Farrell, M., Murphy, C. S., D\u2019Amico, A., Driscoll, H., & Reagan, M. R. (2020). Multiple Myeloma Cells Alter Adipogenesis, Increase Senescence-Related and Inflammatory Gene Transcript Expression, and Alter Metabolism in Preadipocytes. Frontiers in Oncology, 10, 584683. https:\/\/doi.org\/10.3389\/fonc.2020.584683","journal-title":"Frontiers in Oncology"},{"issue":"1","key":"10069_CR137","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/1471-2407-10-198","volume":"10","author":"K Mahtouk","year":"2010","unstructured":"Mahtouk, K., Moreaux, J., Hose, D., Reme, T., Meissner, T., Jourdan, M., Rossi, J. F., Pals, S. T., Goldschmidt, H., & Klein, B. (2010). Growth factors in multiple myeloma: A comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays. BMC Cancer, 10(1), 198. https:\/\/doi.org\/10.1186\/1471-2407-10-198","journal-title":"BMC Cancer"},{"issue":"7","key":"10069_CR138","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1002\/1097-0142(20010401)91:7<1219::aid-cncr1122>3.0.co;2-1","volume":"91","author":"SR Wallace","year":"2001","unstructured":"Wallace, S. R., Oken, M. M., Lunetta, K. L., Panoskaltsis-Mortari, A., & Masellis, A. M. (2001). Abnormalities of bone marrow mesenchymal cells in multiple myeloma patients. Cancer, 91(7), 1219\u20131230. https:\/\/doi.org\/10.1002\/1097-0142(20010401)91:7%3c1219::aid-cncr1122%3e3.0.co;2-1","journal-title":"Cancer"},{"issue":"1","key":"10069_CR139","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/sj.leu.2404466","volume":"21","author":"B Arnulf","year":"2007","unstructured":"Arnulf, B., Lecourt, S., Soulier, J., Ternaux, B., Lacassagne, M. N., Crinquette, A., Dessoly, J., Sciaini, A. K., Benbunan, M., Chomienne, C., Fermand, J. P., Marolleau, J. P., & Larghero, J. (2007). Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma. Leukemia, 21(1), 158\u2013163. https:\/\/doi.org\/10.1038\/sj.leu.2404466","journal-title":"Leukemia"},{"issue":"5","key":"10069_CR140","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1182\/blood-2013-08-524025","volume":"123","author":"T Tanno","year":"2014","unstructured":"Tanno, T., Lim, Y., Wang, Q., Chesi, M., Bergsagel, P. L., Matthews, G., Johnstone, R. W., Ghosh, N., Borrello, I., Huff, C. A., & Matsui, W. (2014). Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cells. Blood, 123(5), 725\u2013733. https:\/\/doi.org\/10.1182\/blood-2013-08-524025","journal-title":"Blood"},{"issue":"6","key":"10069_CR141","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1172\/JCI114392","volume":"84","author":"R Bataille","year":"1989","unstructured":"Bataille, R., Jourdan, M., Zhang, X. G., & Klein, B. (1989). Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias. Journal of Clinical Investigation, 84(6), 2008\u20132011. https:\/\/doi.org\/10.1172\/JCI114392","journal-title":"Journal of Clinical Investigation"},{"issue":"12","key":"10069_CR142","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1182\/blood.V77.12.2794.2794","volume":"77","author":"H Ludwig","year":"1991","unstructured":"Ludwig, H., Nachbaur, D. M., Fritz, E., Krainer, M., & Huber, H. (1991). Interleukin-6 is a prognostic factor in multiple myeloma. Blood, 77(12), 2794\u20132795.\u00a0https:\/\/doi.org\/10.1182\/blood.V77.12.2794.2794","journal-title":"Blood"},{"issue":"3","key":"10069_CR143","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1182\/blood.V85.3.765.bloodjournal853765","volume":"85","author":"TT Pelliniemi","year":"1995","unstructured":"Pelliniemi, T. T., Irjala, K., Mattila, K., Pulkki, K., Rajamaki, A., Tienhaara, A., Laakso, M., & Lahtinen, R. (1995). Immunoreactive interleukin-6 and acute phase proteins as prognostic factors in multiple myeloma. Blood, 85(3), 765\u2013771.\u00a0https:\/\/doi.org\/10.1182\/blood.V85.3.765.bloodjournal853765","journal-title":"Blood"},{"issue":"3\u20134","key":"10069_CR144","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3109\/10428199409059598","volume":"12","author":"J Thaler","year":"1994","unstructured":"Thaler, J., Fechner, F., Herold, M., & Huber, H. (1994). Interleukin-6 in multiple myeloma: Correlation with disease activity and Ki-67 proliferation index. Leukemia & Lymphoma, 12(3\u20134), 265\u2013271. https:\/\/doi.org\/10.3109\/10428199409059598","journal-title":"Leukemia & Lymphoma"},{"key":"10069_CR145","doi-asserted-by":"publisher","unstructured":"Banaszkiewicz, M., Malyszko, J., Batko, K., Koc-Zorawska, E., Zorawski, M., Dumnicka, P., Jurczyszyn, A., Woziwodzka, K., Tisonczyk, J., Krzanowski, M., Malyszko, J., Waszczuk-Gajda, A., Drozdz, R., Kuzniewski, M., & Krzanowska, K. (2020). Evaluating the relationship of GDF-15 with clinical characteristics, cardinal features, and survival in multiple myeloma. Mediators of Inflammation, 5657864. https:\/\/doi.org\/10.1155\/2020\/5657864","DOI":"10.1155\/2020\/5657864"},{"issue":"1","key":"10069_CR146","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00277-002-0558-0","volume":"82","author":"MG Alexandrakis","year":"2003","unstructured":"Alexandrakis, M. G., Passam, F. H., Boula, A., Christophoridou, A., Aloizos, G., Roussou, P., & Kyriakou, D. S. (2003). Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma. Annals of Hematology, 82(1), 19\u201323. https:\/\/doi.org\/10.1007\/s00277-002-0558-0","journal-title":"Annals of Hematology"},{"issue":"6","key":"10069_CR147","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1158\/0008-5472.CAN-11-0188","volume":"72","author":"J Corre","year":"2012","unstructured":"Corre, J., Labat, E., Espagnolle, N., Hebraud, B., Avet-Loiseau, H., Roussel, M., Huynh, A., Gadelorge, M., Cordelier, P., Klein, B., Moreau, P., Facon, T., Fournie, J. J., Attal, M., & Bourin, P. (2012). Bioactivity and prognostic significance of growth differentiation factor GDF15 secreted by bone marrow mesenchymal stem cells in multiple myeloma. Cancer Research, 72(6), 1395\u20131406. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-0188","journal-title":"Cancer Research"},{"issue":"3","key":"10069_CR148","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1159\/000354835","volume":"131","author":"P Tarkun","year":"2014","unstructured":"Tarkun, P., Birtas Atesoglu, E., Mehtap, O., Musul, M. M., & Hacihanefioglu, A. (2014). Serum growth differentiation factor 15 levels in newly diagnosed multiple myeloma patients. Acta Haematologica, 131(3), 173\u2013178. https:\/\/doi.org\/10.1159\/000354835","journal-title":"Acta Haematologica"},{"issue":"3","key":"10069_CR149","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s12185-014-1626-7","volume":"100","author":"S Mei","year":"2014","unstructured":"Mei, S., Wang, H., Fu, R., Qu, W., Xing, L., Wang, G., Song, J., Liu, H., Li, L., Wang, X., Wu, Y., Guan, J., Ruan, E., & Shao, Z. (2014). Hepcidin and GDF15 in anemia of multiple myeloma. International Journal of Hematology, 100(3), 266\u2013273. https:\/\/doi.org\/10.1007\/s12185-014-1626-7","journal-title":"International Journal of Hematology"},{"issue":"2","key":"10069_CR150","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.cyto.2014.05.017","volume":"69","author":"A Zingone","year":"2014","unstructured":"Zingone, A., Wang, W., Corrigan-Cummins, M., Wu, S. P., Plyler, R., Korde, N., Kwok, M., Manasanch, E. E., Tageja, N., Bhutani, M., Mulquin, M., Zuchlinski, D., Yancey, M. A., Roschewski, M., Zhang, Y., Roccaro, A. M., Ghobrial, I. M., Calvo, K. R., & Landgren, O. (2014). Altered cytokine and chemokine profiles in multiple myeloma and its precursor disease. Cytokine, 69(2), 294\u2013297. https:\/\/doi.org\/10.1016\/j.cyto.2014.05.017","journal-title":"Cytokine"},{"issue":"10","key":"10069_CR151","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1002\/(SICI)1097-0142(19980515)82:10%3c1860::AID-CNCR7%3e3.0.CO;2-R","volume":"82","author":"R Stasi","year":"1998","unstructured":"Stasi, R., Brunetti, M., Parma, A., Di Giulio, C., Terzoli, E., & Pagano, A. (1998). The prognostic value of soluble interleukin-6 receptor in patients with multiple myeloma. Cancer, 82(10), 1860\u20131866. https:\/\/doi.org\/10.1002\/(SICI)1097-0142(19980515)82:10%3c1860::AID-CNCR7%3e3.0.CO;2-R","journal-title":"Cancer"},{"issue":"12","key":"10069_CR152","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.1182\/blood.V82.12.3712.3712","volume":"82","author":"H Uchiyama","year":"1993","unstructured":"Uchiyama, H., Barut, B. A., Mohrbacher, A. F., Chauhan, D., & Anderson, K. C. (1993). Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion. Blood, 82(12), 3712\u20133720.\u00a0https:\/\/doi.org\/10.1182\/blood.V82.12.3712.3712","journal-title":"Blood"},{"issue":"9","key":"10069_CR153","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/mc.22378","volume":"55","author":"O Attar-Schneider","year":"2016","unstructured":"Attar-Schneider, O., Zismanov, V., Dabbah, M., Tartakover-Matalon, S., Drucker, L., & Lishner, M. (2016). Multiple myeloma and bone marrow mesenchymal stem cells\u2019 crosstalk: Effect on translation initiation. Molecular Carcinogenesis, 55(9), 1343\u20131354. https:\/\/doi.org\/10.1002\/mc.22378","journal-title":"Molecular Carcinogenesis"},{"issue":"4","key":"10069_CR154","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1172\/JCI66517","volume":"123","author":"AM Roccaro","year":"2013","unstructured":"Roccaro, A. M., Sacco, A., Maiso, P., Azab, A. K., Tai, Y. T., Reagan, M., Azab, F., Flores, L. M., Campigotto, F., Weller, E., Anderson, K. C., Scadden, D. T., & Ghobrial, I. M. (2013). BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression. Journal of Clinical Investigation, 123(4), 1542\u20131555. https:\/\/doi.org\/10.1172\/JCI66517","journal-title":"Journal of Clinical Investigation"},{"issue":"3","key":"10069_CR155","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/stem.2499","volume":"35","author":"M Kanehira","year":"2017","unstructured":"Kanehira, M., Fujiwara, T., Nakajima, S., Okitsu, Y., Onishi, Y., Fukuhara, N., Ichinohasama, R., Okada, Y., & Harigae, H. (2017). An lysophosphatidic acid receptors 1 and 3 axis governs cellular senescence of mesenchymal stromal cells and promotes growth and vascularization of multiple myeloma. Stem Cells, 35(3), 739\u2013753. https:\/\/doi.org\/10.1002\/stem.2499","journal-title":"Stem Cells"},{"issue":"6","key":"10069_CR156","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1182\/blood.V88.6.2219.bloodjournal8862219","volume":"88","author":"M Urashima","year":"1996","unstructured":"Urashima, M., Ogata, A., Chauhan, D., Vidriales, M., Teoh, G., Hoshi, Y., Schlossman, R., DeCaprio, J., & Anderson, K. (1996). Interleukin-6 promotes multiple myeloma cell growth via phosphorylation of retinoblastoma protein. Blood, 88(6), 2219\u20132227. https:\/\/doi.org\/10.1182\/blood.V88.6.2219.bloodjournal8862219","journal-title":"Blood"},{"issue":"7","key":"10069_CR157","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1182\/blood.V84.7.2269.2269","volume":"84","author":"HM Lokhorst","year":"1994","unstructured":"Lokhorst, H. M., Lamme, T., de Smet, M., Klein, S., de Weger, R. A., van Oers, R., & Bloem, A. C. (1994). Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures. Blood, 84(7), 2269\u20132277.\u00a0https:\/\/doi.org\/10.1182\/blood.V84.7.2269.2269","journal-title":"Blood"},{"issue":"2","key":"10069_CR158","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1182\/blood.V73.2.517.517","volume":"73","author":"B Klein","year":"1989","unstructured":"Klein, B., Zhang, X. G., Jourdan, M., Content, J., Houssiau, F., Aarden, L., Piechaczyk, M., & Bataille, R. (1989). Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood, 73(2), 517\u2013526. https:\/\/doi.org\/10.1182\/blood.V73.2.517.517","journal-title":"Blood"},{"issue":"1","key":"10069_CR159","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1182\/blood.V74.1.11.11","volume":"74","author":"XG Zhang","year":"1989","unstructured":"Zhang, X. G., Klein, B., & Bataille, R. (1989). Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma. Blood, 74(1), 11\u201313.\u00a0https:\/\/doi.org\/10.1182\/blood.V74.1.11.11","journal-title":"Blood"},{"issue":"23","key":"10069_CR160","doi-asserted-by":"publisher","first-page":"7144","DOI":"10.1158\/1078-0432.CCR-09-1483","volume":"15","author":"M Fulciniti","year":"2009","unstructured":"Fulciniti, M., Hideshima, T., Vermot-Desroches, C., Pozzi, S., Nanjappa, P., Shen, Z., Patel, N., Smith, E. S., Wang, W., Prabhala, R., Tai, Y. T., Tassone, P., Anderson, K. C., & Munshi, N. C. (2009). A high-affinity fully human anti-IL-6 mAb, 1339, for the treatment of multiple myeloma. Clinical Cancer Research, 15(23), 7144\u20137152. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-1483","journal-title":"Clinical Cancer Research"},{"key":"10069_CR161","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.leukres.2015.10.004","volume":"40","author":"HK Teoh","year":"2016","unstructured":"Teoh, H. K., Chong, P. P., Abdullah, M., Sekawi, Z., Tan, G. C., Leong, C. F., & Cheong, S. K. (2016). Small interfering RNA silencing of interleukin-6 in mesenchymal stromal cells inhibits multiple myeloma cell growth. Leukemia Research, 40, 44\u201353. https:\/\/doi.org\/10.1016\/j.leukres.2015.10.004","journal-title":"Leukemia Research"},{"issue":"9","key":"10069_CR162","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/sj.bmt.1705138","volume":"36","author":"JF Rossi","year":"2005","unstructured":"Rossi, J. F., Fegueux, N., Lu, Z. Y., Legouffe, E., Exbrayat, C., Bozonnat, M. C., Navarro, R., Lopez, E., Quittet, P., Daures, J. P., Rouille, V., Kanouni, T., Widjenes, J., & Klein, B. (2005). Optimizing the use of anti-interleukin-6 monoclonal antibody with dexamethasone and 140 mg\/m2 of melphalan in multiple myeloma: Results of a pilot study including biological aspects. Bone Marrow Transplantation, 36(9), 771\u2013779. https:\/\/doi.org\/10.1038\/sj.bmt.1705138","journal-title":"Bone Marrow Transplantation"},{"issue":"3","key":"10069_CR163","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1046\/j.1365-2141.2000.02093.x","volume":"109","author":"P Moreau","year":"2000","unstructured":"Moreau, P., Harousseau, J. L., Wijdenes, J., Morineau, N., Milpied, N., & Bataille, R. (2000). A combination of anti-interleukin 6 murine monoclonal antibody with dexamethasone and high-dose melphalan induces high complete response rates in advanced multiple myeloma. British Journal of Haematology, 109(3), 661\u2013664. https:\/\/doi.org\/10.1046\/j.1365-2141.2000.02093.x","journal-title":"British Journal of Haematology"},{"issue":"3","key":"10069_CR164","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/bjh.12266","volume":"161","author":"PM Voorhees","year":"2013","unstructured":"Voorhees, P. M., Manges, R. F., Sonneveld, P., Jagannath, S., Somlo, G., Krishnan, A., Lentzsch, S., Frank, R. C., Zweegman, S., Wijermans, P. W., Orlowski, R. Z., Kranenburg, B., Hall, B., Casneuf, T., Qin, X., van de Velde, H., Xie, H., & Thomas, S. K. (2013). A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma. British Journal of Haematology, 161(3), 357\u2013366. https:\/\/doi.org\/10.1111\/bjh.12266","journal-title":"British Journal of Haematology"},{"issue":"13","key":"10069_CR165","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.1158\/1078-0432.CCR-18-3470","volume":"25","author":"TA Brighton","year":"2019","unstructured":"Brighton, T. A., Khot, A., Harrison, S. J., Ghez, D., Weiss, B. M., Kirsch, A., Magen, H., Gironella, M., Oriol, A., Streetly, M., Kranenburg, B., Qin, X., Bandekar, R., Hu, P., Guilfoyle, M., Qi, M., Nemat, S., & Goldschmidt, H. (2019). Randomized, double-blind, placebo-controlled, multicenter study of siltuximab in high-risk smoldering multiple myeloma. Clinical Cancer Research, 25(13), 3772\u20133775. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-3470","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"10069_CR166","first-page":"65","volume":"10","author":"M Jourdan","year":"1999","unstructured":"Jourdan, M., Tarte, K., Legouffe, E., Brochier, J., Rossi, J. F., & Klein, B. (1999). Tumor necrosis factor is a survival and proliferation factor for human myeloma cells. European Cytokine Network, 10(1), 65\u201370.","journal-title":"European Cytokine Network"},{"key":"10069_CR167","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3389\/fimmu.2017.01347","volume":"8","author":"A Bosseboeuf","year":"2017","unstructured":"Bosseboeuf, A., Allain-Maillet, S., Mennesson, N., Tallet, A., Rossi, C., Garderet, L., Caillot, D., Moreau, P., Piver, E., Girodon, F., Perreault, H., Brouard, S., Nicot, A., Bigot-Corbel, E., Hermouet, S., & Harb, J. (2017). Pro-inflammatory state in monoclonal gammopathy of undetermined significance and in multiple myeloma is characterized by low sialylation of pathogen-specific and other monoclonal immunoglobulins. Frontiers in Immunology, 8, 1347. https:\/\/doi.org\/10.3389\/fimmu.2017.01347","journal-title":"Frontiers in Immunology"},{"issue":"4","key":"10069_CR168","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ejim.2012.01.012","volume":"23","author":"G Tsirakis","year":"2012","unstructured":"Tsirakis, G., Pappa, C. A., Spanoudakis, M., Chochlakis, D., Alegakis, A., Psarakis, F. E., Stratinaki, M., Stathopoulos, E. N., & Alexandrakis, M. G. (2012). Clinical significance of sCD105 in angiogenesis and disease activity in multiple myeloma. European Journal of Internal Medicine, 23(4), 368\u2013373. https:\/\/doi.org\/10.1016\/j.ejim.2012.01.012","journal-title":"European Journal of Internal Medicine"},{"issue":"41","key":"10069_CR169","doi-asserted-by":"publisher","first-page":"69408","DOI":"10.18632\/oncotarget.11242","volume":"8","author":"P Schneiderova","year":"2017","unstructured":"Schneiderova, P., Pika, T., Gajdos, P., Fillerova, R., Kromer, P., Kudelka, M., Minarik, J., Papajik, T., Scudla, V., & Kriegova, E. (2017). Serum protein fingerprinting by PEA immunoassay coupled with a pattern-recognition algorithms distinguishes MGUS and multiple myeloma. Oncotarget, 8(41), 69408\u201369421. https:\/\/doi.org\/10.18632\/oncotarget.11242","journal-title":"Oncotarget"},{"issue":"1","key":"10069_CR170","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1365-2249.1993.tb05943.x","volume":"92","author":"F Merico","year":"1993","unstructured":"Merico, F., Bergui, L., Gregoretti, M. G., Ghia, P., Aimo, G., Lindley, I. J., & Caligaris-Cappio, F. (1993). Cytokines involved in the progression of multiple myeloma. Clinical Experimental Immunology, 92(1), 27\u201331. https:\/\/doi.org\/10.1111\/j.1365-2249.1993.tb05943.x","journal-title":"Clinical Experimental Immunology"},{"issue":"5","key":"10069_CR171","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1007\/s11357-021-00440-z","volume":"43","author":"S Tarantini","year":"2021","unstructured":"Tarantini, S., Balasubramanian, P., Delfavero, J., Csipo, T., Yabluchanskiy, A., Kiss, T., Nyul-Toth, A., Mukli, P., Toth, P., Ahire, C., Ungvari, A., Benyo, Z., Csiszar, A., & Ungvari, Z. (2021). Treatment with the BCL-2\/BCL-xL inhibitor senolytic drug ABT263\/Navitoclax improves functional hyperemia in aged mice. Geroscience, 43(5), 2427\u20132440. https:\/\/doi.org\/10.1007\/s11357-021-00440-z","journal-title":"Geroscience"},{"issue":"2","key":"10069_CR172","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ijrobp.2017.02.216","volume":"99","author":"J Pan","year":"2017","unstructured":"Pan, J., Li, D., Xu, Y., Zhang, J., Wang, Y., Chen, M., Lin, S., Huang, L., Chung, E. J., Citrin, D. E., Wang, Y., Hauer-Jensen, M., Zhou, D., & Meng, A. (2017). Inhibition of Bcl-2\/xl with ABT-263 selectively kills senescent type II pneumocytes and reverses persistent pulmonary fibrosis induced by ionizing radiation in mice. International Journal of Radiation Oncology Biology Physics, 99(2), 353\u2013361. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.02.216","journal-title":"International Journal of Radiation Oncology Biology Physics"},{"issue":"1","key":"10069_CR173","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/nm.4010","volume":"22","author":"J Chang","year":"2016","unstructured":"Chang, J., Wang, Y., Shao, L., Laberge, R.-M., Demaria, M., Campisi, J., Janakiraman, K., Sharpless, N. E., Ding, S., Feng, W., Luo, Y., Wang, X., Aykin-Burns, N., Krager, K., Ponnappan, U., Hauer-Jensen, M., Meng, A., & Zhou, D. (2016). Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice. Nature Medicine, 22(1), 78\u201383. https:\/\/doi.org\/10.1038\/nm.4010","journal-title":"Nature Medicine"},{"issue":"4","key":"10069_CR174","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/acel.12597","volume":"16","author":"HN Kim","year":"2017","unstructured":"Kim, H. N., Chang, J., Shao, L., Han, L., Iyer, S., Manolagas, S. C., O\u2019Brien, C. A., Jilka, R. L., Zhou, D., & Almeida, M. (2017). DNA damage and senescence in osteoprogenitors expressing Osx1 may cause their decrease with age. Aging Cell, 16(4), 693\u2013703. https:\/\/doi.org\/10.1111\/acel.12597","journal-title":"Aging Cell"},{"key":"10069_CR175","doi-asserted-by":"publisher","unstructured":"Sharma, A. K., Roberts, R. L., Benson, R. D., Jr., Pierce, J. L., Yu, K., Hamrick, M. W., & McGee-Lawrence, M. E. (2020). The senolytic drug navitoclax (ABT-263) causes trabecular bone loss and impaired osteoprogenitor function in aged mice. Frontiers in Cell and Developmental Biology, 8(354). https:\/\/doi.org\/10.3389\/fcell.2020.00354","DOI":"10.3389\/fcell.2020.00354"},{"issue":"1","key":"10069_CR176","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13287-018-0857-6","volume":"9","author":"C Grezella","year":"2018","unstructured":"Grezella, C., Fernandez-Rebollo, E., Franzen, J., Ventura Ferreira, M. S., Beier, F., & Wagner, W. (2018). Effects of senolytic drugs on human mesenchymal stromal cells. Stem Cell Research & Therapy, 9(1), 108. https:\/\/doi.org\/10.1186\/s13287-018-0857-6","journal-title":"Stem Cell Research & Therapy"},{"key":"10069_CR177","doi-asserted-by":"publisher","unstructured":"Song, X., Dai, J., Li, H., Li, Y., Hao, W., Zhang, Y., Zhang, Y., Su, L., & Wei, H. (2019). Anti-aging effects exerted by Tetramethylpyrazine enhances self-renewal and neuronal differentiation of rat bMSCs by suppressing NF-kB signaling. Bioscience Reports, 39(6). https:\/\/doi.org\/10.1042\/BSR20190761","DOI":"10.1042\/BSR20190761"},{"issue":"3","key":"10069_CR178","doi-asserted-by":"publisher","first-page":"e12741","DOI":"10.1111\/acel.12741","volume":"17","author":"B Gao","year":"2018","unstructured":"Gao, B., Lin, X., Jing, H., Fan, J., Ji, C., Jie, Q., Zheng, C., Wang, D., Xu, X., Hu, Y., Lu, W., Luo, Z., & Yang, L. (2018). Local delivery of tetramethylpyrazine eliminates the senescent phenotype of bone marrow mesenchymal stromal cells and creates an anti-inflammatory and angiogenic environment in aging mice. Aging Cell, 17(3), e12741. https:\/\/doi.org\/10.1111\/acel.12741","journal-title":"Aging Cell"},{"issue":"4","key":"10069_CR179","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/acel.12344","volume":"14","author":"Y Zhu","year":"2015","unstructured":"Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., O\u2019Hara, S. P., LaRusso, N. F., Miller, J. D., Roos, C. M., Verzosa, G. C., LeBrasseur, N. K., Wren, J. D., Farr, J. N., Khosla, S., Stout, M. B., et al. (2015). The Achilles\u2019 heel of senescent cells: From transcriptome to senolytic drugs. Aging Cell, 14(4), 644\u2013658. https:\/\/doi.org\/10.1111\/acel.12344","journal-title":"Aging Cell"},{"issue":"9","key":"10069_CR180","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/nm.4385","volume":"23","author":"JN Farr","year":"2017","unstructured":"Farr, J. N., Xu, M., Weivoda, M. M., Monroe, D. G., Fraser, D. G., Onken, J. L., Negley, B. A., Sfeir, J. G., Ogrodnik, M. B., Hachfeld, C. M., LeBrasseur, N. K., Drake, M. T., Pignolo, R. J., Pirtskhalava, T., Tchkonia, T., Oursler, M. J., Kirkland, J. L., & Khosla, S. (2017). Targeting cellular senescence prevents age-related bone loss in mice. Nature Medicine, 23(9), 1072\u20131079. https:\/\/doi.org\/10.1038\/nm.4385","journal-title":"Nature Medicine"},{"key":"10069_CR181","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.ebiom.2019.08.069","volume":"47","author":"LJ Hickson","year":"2019","unstructured":"Hickson, L. J., Langhi Prata, L. G. P., Bobart, S. A., Evans, T. K., Giorgadze, N., Hashmi, S. K., Herrmann, S. M., Jensen, M. D., Jia, Q., Jordan, K. L., Kellogg, T. A., Khosla, S., Koerber, D. M., Lagnado, A. B., Lawson, D. K., LeBrasseur, N. K., Lerman, L. O., McDonald, K. M., McKenzie, T. J., Passos, J. F., et al. (2019). Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of dasatinib plus quercetin in individuals with diabetic kidney disease. eBioMedicine, 47, 446\u2013456. https:\/\/doi.org\/10.1016\/j.ebiom.2019.08.069","journal-title":"eBioMedicine"},{"key":"10069_CR182","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.ebiom.2018.12.052","volume":"40","author":"JN Justice","year":"2019","unstructured":"Justice, J. N., Nambiar, A. M., Tchkonia, T., LeBrasseur, N. K., Pascual, R., Hashmi, S. K., Prata, L., Masternak, M. M., Kritchevsky, S. B., Musi, N., & Kirkland, J. L. (2019). Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study. eBioMedicine, 40, 554\u2013563. https:\/\/doi.org\/10.1016\/j.ebiom.2018.12.052","journal-title":"eBioMedicine"},{"issue":"3\u20134","key":"10069_CR183","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3109\/10428199409059598","volume":"12","author":"J Thaler","year":"1994","unstructured":"Thaler, J., Fechner, F., Herold, M., & Huber, H. (1994). Interleukin-6 in multiple myeloma: Correlation with disease activity and Ki-67 proliferation index. Leukaemia & Lymphoma, 12(3\u20134), 265\u2013271. https:\/\/doi.org\/10.3109\/10428199409059598","journal-title":"Leukaemia & Lymphoma"},{"key":"10069_CR184","doi-asserted-by":"publisher","first-page":"5657864","DOI":"10.1155\/2020\/5657864","volume":"2020","author":"M Banaszkiewicz","year":"2020","unstructured":"Banaszkiewicz, M., Malyszko, J., Batko, K., Koc-Zorawska, E., Zorawski, M., Dumnicka, P., Jurczyszyn, A., Woziwodzka, K., Tisonczyk, J., Krzanowski, M., Malyszko, J., Waszczuk-Gajda, A., Drozdz, R., Kuzniewski, M., & Krzanowska, K. (2020). Evaluating the relationship of GDF-15 with clinical characteristics, cardinal features, and survival in multiple myeloma. Mediators of Inflammation, 2020, 5657864. https:\/\/doi.org\/10.1155\/2020\/5657864","journal-title":"Mediators of Inflammation"},{"key":"10069_CR185","doi-asserted-by":"publisher","first-page":"3864948","DOI":"10.1155\/2019\/3864948","volume":"2019","author":"X Bonilla","year":"2019","unstructured":"Bonilla, X., Vanegas, N. P., & Vernot, J. P. (2019). Acute leukemia induces senescence and impaired osteogenic differentiation in mesenchymal stem cells endowing leukemic cells with functional advantages. Stem Cells International, 2019, 3864948. https:\/\/doi.org\/10.1155\/2019\/3864948","journal-title":"Stem Cells International"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-022-10069-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-022-10069-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-022-10069-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T07:21:18Z","timestamp":1678778478000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-022-10069-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,9]]},"references-count":185,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10069"],"URL":"https:\/\/doi.org\/10.1007\/s10555-022-10069-9","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,9]]},"assertion":[{"value":"27 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}